Professor Gareth Evans

Photograph of Gareth Evans

Professor of Medical Genetics and Cancer Epidemiology

Genomic Medicine,

Manchester Academic Health Science Centre,

The University of Manchester,

Central Manchester University Hospitals NHS Foundation Trust,

Saint Mary's Hospital, Oxford Road, Manchester M13 9WL, UK

Role

Professor of Medical Genetics and Cancer Epidemiology, The University of Manchester

Consultant in Medical Genetics and Cancer Epidemiology, Central Manchester Hospitals NHS Foundation Trust and The Christie NHS Foundation Trust

Memberships of Committees and Professional Bodies

Member and Ex Council Member of the Clinical Genetics Society

Member and Ex Chairman of the Cancer Genetics Group

Member and ex Council Member of the British Society of Genetimic Medicine

Member Europoean Society of Human Genetics

 

Teaching

1. a) Medical student clinical course teaching (full year seminars). Medical student options two per year, 3 in 1995.

    b) MSc in genetic counselling

    c) teaching of registrar/SR grades internally + lectures to SHO and registrars in paediatrics and obstetrics.

    d) Postgraduate lectures throughout region.

    e) Postgraduate education representative of department.

2. a) FRCR in clinical oncology seminars - Christie hospital

     b) MSc in medical oncology seminars - Christie hospital

     c) MSc in cancer genetics - Royal Marsden hospital.

3. Devised and supervise Breast Cancer Genetics Training course for breast care nurses and clinicians. Approved by Director of Cancer Services (Region) and School of Nursing.

 

Biography

Professor Evans has established a national and international reputation in clinical and research aspects of cancer genetics, particularly in neurofibromatosis and breast cancer. He has developed a clinical service for cancer genetics in the North West Region of England, which is nationally regarded. He is an important opinion leader nationally through membership of committees and was chairman of the NICE Familial Breast Cancer Guideline Development Group (2002-2010) and is now clinical lead (2011-). He lectures throughout the UK and internationally on hereditary breast cancer and cancer syndromes. He has given plenary lectures at many international meetings including the International Congress of Human Genetics and two invited lecture tours across Australia (1995, 2001). He has developed a national training program for clinicians, nurses and genetic counsellors in breast cancer genetics and established a system for risk assessment and counselling for breast cancer in Calman breast units implemented through a training course (1998-2011).

 

He has published 537 peer reviewed research publications; 204 as first or senior author. He has published over 90 reviews and chapters and has had a book published by Oxford University Press on familial cancer. He has an ISI web of knowledge H-index of 73 having only published his first article in 1990. In the last 5 years he has raised over £10 million in grants for multicentre and local studies – approximately £5 million to Manchester. He is Chief Investigator on a £1.59 million NIHR program grant (2009-2014) on breast cancer risk prediction and also has an NIHR RfPB grant as CI (2011).  He has lead a successful bid for a Nationally funded NF2 service (£7.5 million pa) that started in 2010 and is involved in the national complex NF1 service.

Research interests

  • inherited breast and ovarian cancer and its imaging
  • Neurofibromatosis types 1 and 2 and imaging
  • Other inherited tumour predispositions

 

Qualifications

MB BS MRCP MD FRCP

Collaborators and affiliated staff

Dr Miriam Smith

Helen Burney

Elaine Harkness

Dr William Newman

Prof Tony Howell

Publications

2014

  • Armstrong, A. & Evans, G (2014). Management of women at high risk of breast cancer. BMJ, 348, g2756. eScholarID:239406 | PMID:24778341
  • Bancroft, et al (2014). Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study. Eur Urol, 66(3), 489-99. eScholarID:239112 | PMID:24484606 | DOI:10.1016/j.eururo.2014.01.003
  • Bancroft, et al (2014). Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study. Eur Urol, 66(3), 489-99. eScholarID:239396 | PMID:24484606 | DOI:10.1016/j.eururo.2014.01.003
  • Bholah, Z., Smith, M., Byers, H., Miles, E., Evans, D. & Newman, W (2014). Intronic splicing mutations in PTCH1 cause Gorlin syndrome. Fam Cancer, 13(3), 477-80. eScholarID:239102 | PMID:24659465 | DOI:10.1007/s10689-014-9712-9
  • Bholah, Z., Smith, M., Byers, H., Miles, E., Evans, D. & Newman, W (2014). Intronic splicing mutations in PTCH1 cause Gorlin syndrome. Fam Cancer, 13(3), 477-80. eScholarID:239382 | PMID:24659465 | DOI:10.1007/s10689-014-9712-9
  • Blakeley, J., Schreck, K., Evans, D., Korf, B., Zagzag, D., Karajannis, M., Bergner, A. & Belzberg, A (2014). Clinical response to bevacizumab in schwannomatosis. Neurology, eScholarID:239092 | PMID:25339217 | DOI:10.1212/WNL.0000000000000997
  • Brentnall AR, Evans DG, Cuzick J. (2014). Distribution of breast cancer risk from SNPs and classical risk factors in women of routine screening age in the UK. 110(3), 827-828. eScholarID:239147
  • Chai, X., Friebel, T., Singer, C., Evans, D., Lynch, H., Isaacs, C., Garber, J., Neuhausen, S., Matloff, E., Eeles, R., Tung, N., Weitzel, J., Couch, F., Hulick, P., Ganz, P., Daly, M., Olopade, O., Tomlinson, G., Blum, J., Domchek, S., Chen, J. & Rebbeck, T (2014). Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat, eScholarID:239117 | PMID:25311111 | DOI:10.1007/s10549-014-3134-0
  • Copson, E., Maishman, T., Gerty, S., Eccles, B., Stanton, L., Cutress, R., Altman, D., Durcan, L., Simmonds, P., Jones, L., Tapper, W., , & Eccles, D (2014). Ethnicity and outcome of young breast cancer patients in the United Kingdom: the POSH study. Br J Cancer, 110(1), 230-41. eScholarID:239130 | PMID:24149174 | DOI:10.1038/bjc.2013.650
  • Copson, E., Maishman, T., Gerty, S., Eccles, B., Stanton, L., Cutress, R., Altman, D., Durcan, L., Simmonds, P., Jones, L., Tapper, W., , & Eccles, D (2014). Ethnicity and outcome of young breast cancer patients in the United Kingdom: the POSH study. Br J Cancer, 110(1), 230-41. eScholarID:239405 | PMID:24149174 | DOI:10.1038/bjc.2013.650
  • Donnelly, L., Evans, D., Wiseman, J., Fox, J., Greenhalgh, R., Affen, J., Juraskova, I., Stavrinos, P., Dawe, S., Cuzick, J. & Howell, A (2014). Uptake of tamoxifen in consecutive premenopausal women under surveillance in a high-risk breast cancer clinic. Br J Cancer, 110(7), 1681-7. eScholarID:239118 | PMID:24594998 | DOI:10.1038/bjc.2014.109
  • Donnelly, L., Evans, D., Wiseman, J., Fox, J., Greenhalgh, R., Affen, J., Juraskova, I., Stavrinos, P., Dawe, S., Cuzick, J. & Howell, A (2014). Uptake of tamoxifen in consecutive premenopausal women under surveillance in a high-risk breast cancer clinic. Br J Cancer, 110(7), 1681-7. eScholarID:239401 | PMID:24594998 | DOI:10.1038/bjc.2014.109
  • Evans, D., Brentnall, A., Harvie, M., Dawe, S., Sergeant, J., Stavrinos, P., Astley, S., Wilson, M., Ainsworth, J., Cuzick, J., Buchan, I., Donnelly, L. & Howell, A (2014). Breast Cancer Risk in Young Women in the National Breast Screening Programme: Implications for Applying NICE Guidelines for Additional Screening and Chemoprevention. Cancer Prev Res (Phila), 7(10), 993-1001. eScholarID:239372 | PMID:25047362 | DOI:10.1158/1940-6207.CAPR-14-0037
  • Evans, D., Gareth, E., Kesavan, N., Nisha, K., Lim, Y., Yit, L., Gadde, S., Soujanye, G., Hurley, E., Emma, H., Massat, N., Maxwell, A., Ingham, S., Sarah, I., Eeles, R., Rosalind, E., Leach, M., , , Howell, A., Anthony, H., Duffy, S. & Stephen, D (2014). MRI breast screening in high-risk women: cancer detection and survival analysis. Breast Cancer Res Treat, 145(3), 663-72. eScholarID:239109 | PMID:24687378 | DOI:10.1007/s10549-014-2931-9
  • Evans, D., Gareth, E., Kesavan, N., Nisha, K., Lim, Y., Yit, L., Gadde, S., Soujanye, G., Hurley, E., Emma, H., Massat, N., Maxwell, A., Ingham, S., Sarah, I., Eeles, R., Rosalind, E., Leach, M., , , Howell, A., Anthony, H., Duffy, S. & Stephen, D (2014). MRI breast screening in high-risk women: cancer detection and survival analysis. Breast Cancer Res Treat, 145(3), 663-72. eScholarID:239387 | PMID:24687378 | DOI:10.1007/s10549-014-2931-9
  • Evans, D., Harkness, E., Lalloo, F. & Howell, A (2014). Long-term prospective clinical follow-up after BRCA1/2 presymptomatic testing: BRCA2 risks higher than in adjusted retrospective studies. J Med Genet, 51(9), 573-80. eScholarID:239100 | PMID:25053764 | DOI:10.1136/jmedgenet-2014-102336
  • Evans, D., Harkness, E., Lalloo, F. & Howell, A (2014). Long-term prospective clinical follow-up after BRCA1/2 presymptomatic testing: BRCA2 risks higher than in adjusted retrospective studies. J Med Genet, 51(9), 573-80. eScholarID:239384 | PMID:25053764 | DOI:10.1136/jmedgenet-2014-102336
  • Evans, D., Ingham, S., Dawe, S., Roberts, L., Lalloo, F., Brentnall, A., Stavrinos, P. & Howell, A (2014). Breast cancer risk assessment in 8,824 women attending a family history evaluation and screening programme. Fam Cancer, 13(2), 189-96. eScholarID:239374 | PMID:24276527 | DOI:10.1007/s10689-013-9694-z
  • Ferner, R., Shaw, A., Evans, D., McAleer, D., Halliday, D., Parry, A., Raymond, F., Durie-Gair, J., Hanemann, C., Hornigold, R., Axon, P. & Golding, J (2014). Longitudinal evaluation of quality of life in 288 patients with neurofibromatosis 2. J Neurol, 261(5), 963-9. eScholarID:239101 | PMID:24619350 | DOI:10.1007/s00415-014-7303-1
  • Ferner, R., Shaw, A., Evans, D., McAleer, D., Halliday, D., Parry, A., Raymond, F., Durie-Gair, J., Hanemann, C., Hornigold, R., Axon, P. & Golding, J (2014). Longitudinal evaluation of quality of life in 288 patients with neurofibromatosis 2. J Neurol, 261(5), 963-9. eScholarID:239385 | PMID:24619350 | DOI:10.1007/s00415-014-7303-1
  • Gilkes, C. & Evans, D (2014). Review of radiation therapy services for neurofibromatosis (NF2) patients in England. Br J Neurosurg, 28(1), 16-9. eScholarID:239107 | PMID:24350733 | DOI:10.3109/02688697.2013.861386
  • Gilkes, C. & Evans, D (2014). Review of radiation therapy services for neurofibromatosis (NF2) patients in England. Br J Neurosurg, 28(1), 16-9. eScholarID:239392 | PMID:24350733 | DOI:10.3109/02688697.2013.861386
  • Gronwald, J., Robidoux, A., Kim-Sing, C., Tung, N., Lynch, H., Foulkes, W., Manoukian, S., Ainsworth, P., Neuhausen, S., Demsky, R., Eisen, A., Singer, C., Saal, H., Senter, L., Eng, C., Weitzel, J., Moller, P., Gilchrist, D., Olopade, O., Ginsburg, O., Sun, P., Huzarski, T., Lubinski, J., Narod, S. & . (2014). Duration of tamoxifen use and the risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat, 146(2), 421-7. eScholarID:239129 | PMID:24951267 | DOI:10.1007/s10549-014-3026-3
  • Gronwald, J., Robidoux, A., Kim-Sing, C., Tung, N., Lynch, H., Foulkes, W., Manoukian, S., Ainsworth, P., Neuhausen, S., Demsky, R., Eisen, A., Singer, C., Saal, H., Senter, L., Eng, C., Weitzel, J., Moller, P., Gilchrist, D., Olopade, O., Ginsburg, O., Sun, P., Huzarski, T., Lubinski, J., Narod, S. & . (2014). Duration of tamoxifen use and the risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat, 146(2), 421-7. eScholarID:239403 | PMID:24951267 | DOI:10.1007/s10549-014-3026-3
  • Killick, E., Tymrakiewicz, M., Cieza-Borrella, C., Smith, P., Thompson, D., Pooley, K., Easton, D., Bancroft, E., Page, E., Leongamornlert, D., , , Kote-Jarai, Z. & Eeles, R (2014). Telomere length shows no association with BRCA1 and BRCA2 mutation status. PLoS One, 9(1), e86659. eScholarID:239113 | PMID:24489760 | DOI:10.1371/journal.pone.0086659
  • Killick, E., Tymrakiewicz, M., Cieza-Borrella, C., Smith, P., Thompson, D., Pooley, K., Easton, D., Bancroft, E., Page, E., Leongamornlert, D., , , Kote-Jarai, Z. & Eeles, R (2014). Telomere length shows no association with BRCA1 and BRCA2 mutation status. PLoS One, 9(1), e86659. eScholarID:239397 | PMID:24489760 | DOI:10.1371/journal.pone.0086659
  • Knappskog, et al (2014). Population distribution and ancestry of the cancer protective MDM2 SNP285 (rs117039649). Oncotarget, 5(18), 8223-34. eScholarID:239119 | PMID:25327560
  • Knappskog, et al (2014). Population distribution and ancestry of the cancer protective MDM2 SNP285 (rs117039649). Oncotarget, 5(18), 8223-34. eScholarID:239407 | PMID:25327560
  • Kotsopoulos, J., Lubinski, J., Moller, P., Lynch, H., Singer, C., Eng, C., Neuhausen, S., Karlan, B., Kim-Sing, C., Huzarski, T., Gronwald, J., McCuaig, J., Senter, L., Tung, N., Ghadirian, P., Eisen, A., Gilchrist, D., Blum, J., Zakalik, D., Pal, T., Sun, P., Narod, S. & . (2014). Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers. Breast Cancer Res Treat, 143(3), 579-86. eScholarID:239144 | PMID:24458845 | DOI:10.1007/s10549-013-2823-4
  • Kotsopoulos, J., Lubinski, J., Moller, P., Lynch, H., Singer, C., Eng, C., Neuhausen, S., Karlan, B., Kim-Sing, C., Huzarski, T., Gronwald, J., McCuaig, J., Senter, L., Tung, N., Ghadirian, P., Eisen, A., Gilchrist, D., Blum, J., Zakalik, D., Pal, T., Sun, P., Narod, S. & . (2014). Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers. Breast Cancer Res Treat, 143(3), 579-86. eScholarID:239409 | PMID:24458845 | DOI:10.1007/s10549-013-2823-4
  • Lloyd, S., Glynn, F., Rutherford, S., King, A., Mawman, D., O'Driscoll, M., Evans, D., Ramsden, R. & Freeman, S (2014). Ipsilateral cochlear implantation after cochlear nerve preserving vestibular schwannoma surgery in patients with neurofibromatosis type 2. Otol Neurotol, 35(1), 43-51. eScholarID:239099 | PMID:24335931 | DOI:10.1097/MAO.0000000000000185
  • Lloyd, S., Glynn, F., Rutherford, S., King, A., Mawman, D., O'Driscoll, M., Evans, D., Ramsden, R. & Freeman, S (2014). Ipsilateral cochlear implantation after cochlear nerve preserving vestibular schwannoma surgery in patients with neurofibromatosis type 2. Otol Neurotol, 35(1), 43-51. eScholarID:239383 | PMID:24335931 | DOI:10.1097/MAO.0000000000000185
  • Meyer, S., Tischkowitz, M., Chandler, K., Gillespie, A., Birch, J. & Evans, D (2014). Fanconi anaemia, BRCA2 mutations and childhood cancer: a developmental perspective from clinical and epidemiological observations with implications for genetic counselling. J Med Genet, 51(2), 71-5. eScholarID:239095 | PMID:24259538 | DOI:10.1136/jmedgenet-2013-101642
  • Meyer, S., Tischkowitz, M., Chandler, K., Gillespie, A., Birch, J. & Evans, D (2014). Fanconi anaemia, BRCA2 mutations and childhood cancer: a developmental perspective from clinical and epidemiological observations with implications for genetic counselling. J Med Genet, 51(2), 71-5. eScholarID:239377 | PMID:24259538 | DOI:10.1136/jmedgenet-2013-101642
  • Newton, K., Green, K., Lalloo, F., Evans, D. & Hill, J (2014). Colonoscopy screening compliance and outcomes in patients with Lynch Syndrome. Colorectal Dis, eScholarID:239097 | PMID:25213040 | DOI:10.1111/codi.12778
  • Newton, K., Green, K., Lalloo, F., Evans, D. & Hill, J (2014). Colonoscopy screening compliance and outcomes in patients with Lynch Syndrome. Colorectal Dis, eScholarID:239146 | PMID:25213040 | DOI:10.1111/codi.12778
  • Newton, K., Green, K., Lalloo, F., Evans, D. & Hill, J (2014). Colonoscopy screening compliance and outcomes in patients with Lynch Syndrome. Colorectal Dis, eScholarID:239376 | PMID:25213040 | DOI:10.1111/codi.12778
  • Newton, K., Jorgensen, N., Wallace, A., Buchanan, D., Lalloo, F., McMahon, R., Hill, J. & Evans, D (2014). Tumour MLH1 promoter region methylation testing is an effective prescreen for Lynch Syndrome (HNPCC). J Med Genet, eScholarID:239115 | PMID:25280751 | DOI:10.1136/jmedgenet-2014-102552
  • Newton, K., Jorgensen, N., Wallace, A., Buchanan, D., Lalloo, F., McMahon, R., Hill, J. & Evans, D (2014). Tumour MLH1 promoter region methylation testing is an effective prescreen for Lynch Syndrome (HNPCC). J Med Genet, eScholarID:239399 | PMID:25280751 | DOI:10.1136/jmedgenet-2014-102552
  • Nieuwenhuis, M., Kets, C., Murphy-Ryan, M., Yntema, H., Evans, D., Colas, C., Møller, P., Hes, F., Hodgson, S., Olderode-Berends, M., Aretz, S., Heinimann, K., Gómez García, E., Douglas, F., Spigelman, A., Timshel, S., Lindor, N. & Vasen, H (2014). Cancer risk and genotype-phenotype correlations in PTEN hamartoma tumor syndrome. Fam Cancer, 13(1), 57-63. eScholarID:239371 | PMID:23934601 | DOI:10.1007/s10689-013-9674-3
  • Nippert, I., Julian-Reynier, C., Harris, H., Evans, G., van Asperen, C., Tibben, A. & Schmidtke, J (2014). Cancer risk communication, predictive testing and management in France, Germany, the Netherlands and the UK: general practitioners' and breast surgeons' current practice and preferred practice responsibilities. J Community Genet, 5(1), 69-79. eScholarID:239122 | PMID:24297247 | DOI:10.1007/s12687-013-0173-x
  • Osorio, et al (2014). DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers. PLoS Genet, 10(4), e1004256. eScholarID:239123 | PMID:24698998 | DOI:10.1371/journal.pgen.1004256
  • Osorio, et al (2014). DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers. PLoS Genet, 10(4), e1004256. eScholarID:239404 | PMID:24698998 | DOI:10.1371/journal.pgen.1004256
  • Peterlongo, et al (2014). Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev, eScholarID:239089 | PMID:25336561 | DOI:10.1158/1055-9965.EPI-14-0532
  • Peterlongo, et al (2014). Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev, eScholarID:239375 | PMID:25336561 | DOI:10.1158/1055-9965.EPI-14-0532
  • Plotkin, S., Albers, A., Babovic-Vuksanovic, D., Blakeley, J., Breakefield, X., Dunn, C., Evans, D., Fisher, M., Friedman, J., Giovannini, M., Gutmann, D., Kalamarides, M., McClatchey, A., Messiaen, L., Morrison, H., Parkinson, D., Stemmer-Rachamimov, A., Van Raamsdonk, C., Riccardi, V., Rosser, T., Schindeler, A., Smith, M., Stevenson, D., Ullrich, N., van der Vaart, T., Weiss, B., Widemann, B., Zhu, Y., Bakker, A. & Lloyd, A (2014). Update from the 2013 international neurofibromatosis conference. Am J Med Genet A, eScholarID:239116 | PMID:25255738 | DOI:10.1002/ajmg.a.36754
  • Plotkin, S., Albers, A., Babovic-Vuksanovic, D., Blakeley, J., Breakefield, X., Dunn, C., Evans, D., Fisher, M., Friedman, J., Giovannini, M., Gutmann, D., Kalamarides, M., McClatchey, A., Messiaen, L., Morrison, H., Parkinson, D., Stemmer-Rachamimov, A., Van Raamsdonk, C., Riccardi, V., Rosser, T., Schindeler, A., Smith, M., Stevenson, D., Ullrich, N., van der Vaart, T., Weiss, B., Widemann, B., Zhu, Y., Bakker, A. & Lloyd, A (2014). Update from the 2013 international neurofibromatosis conference. Am J Med Genet A, eScholarID:239400 | PMID:25255738 | DOI:10.1002/ajmg.a.36754
  • Pooley, K., McGuffog, L., Barrowdale, D., Frost, D., Ellis, S., Fineberg, E., Platte, R., Izatt, L., Adlard, J., Bardwell, J., Brewer, C., Cole, T., Cook, J., Davidson, R., Donaldson, A., Dorkins, H., Douglas, F., Eason, J., Houghton, C., Kennedy, M., McCann, E., Miedzybrodzka, Z., Murray, A., Porteous, M., Rogers, M., Side, L., Tischkowitz, M., Walker, L., Hodgson, S., Eccles, D., Morrison, P., Evans, D., Eeles, R., Antoniou, A., Easton, D., Dunning, A. & . (2014). Lymphocyte telomere length is long in BRCA1 and BRCA2 mutation carriers regardless of cancer-affected status. Cancer Epidemiol Biomarkers Prev, 23(6), 1018-24. eScholarID:239104 | PMID:24642354 | DOI:10.1158/1055-9965.EPI-13-0635-T
  • Pooley, K., McGuffog, L., Barrowdale, D., Frost, D., Ellis, S., Fineberg, E., Platte, R., Izatt, L., Adlard, J., Bardwell, J., Brewer, C., Cole, T., Cook, J., Davidson, R., Donaldson, A., Dorkins, H., Douglas, F., Eason, J., Houghton, C., Kennedy, M., McCann, E., Miedzybrodzka, Z., Murray, A., Porteous, M., Rogers, M., Side, L., Tischkowitz, M., Walker, L., Hodgson, S., Eccles, D., Morrison, P., Evans, D., Eeles, R., Antoniou, A., Easton, D., Dunning, A. & . (2014). Lymphocyte telomere length is long in BRCA1 and BRCA2 mutation carriers regardless of cancer-affected status. Cancer Epidemiol Biomarkers Prev, 23(6), 1018-24. eScholarID:239386 | PMID:24642354 | DOI:10.1158/1055-9965.EPI-13-0635-T
  • Prosperi, M., Ingham, S., Howell, A., Lalloo, F., Buchan, I. & Evans, D (2014). Can multiple SNP testing in BRCA2 and BRCA1 female carriers be used to improve risk prediction models in conjunction with clinical assessment? BMC Med Inform Decis Mak, 14(1), 87. eScholarID:239088 | PMID:25274085 | DOI:10.1186/1472-6947-14-87
  • Raffalli-Ebezant, H., Rutherford, S., Stivaros, S., Kelsey, A., Smith, M., Evans, D. & Kilday, J (2014). Pediatric intracranial clear cell meningioma associated with a germline mutation of SMARCE1: a novel case. Childs Nerv Syst, eScholarID:239108 | PMID:25249420 | DOI:10.1007/s00381-014-2558-5
  • Raffalli-Ebezant, H., Rutherford, S., Stivaros, S., Kelsey, A., Smith, M., Evans, D. & Kilday, J (2014). Pediatric intracranial clear cell meningioma associated with a germline mutation of SMARCE1: a novel case. Childs Nerv Syst, eScholarID:239389 | PMID:25249420 | DOI:10.1007/s00381-014-2558-5
  • Smith, M., Wallace, A., Bennett, C., Hasselblatt, M., Elert-Dobkowska, E., Evans, L., Hickey, W., van Hoff, J., Bauer, D., Lee, A., Hevner, R., Beetz, C., du Plessis, D., Kilday, J., Newman, W. & Evans, D (2014). Germline SMARCE1 mutations predispose to both spinal and cranial clear cell meningiomas. J Pathol, eScholarID:239096 | PMID:25143307 | DOI:10.1002/path.4427
  • Smith, M., Wallace, A., Bennett, C., Hasselblatt, M., Elert-Dobkowska, E., Evans, L., Hickey, W., van Hoff, J., Bauer, D., Lee, A., Hevner, R., Beetz, C., du Plessis, D., Kilday, J., Newman, W. & Evans, D (2014). Germline SMARCE1 mutations predispose to both spinal and cranial clear cell meningiomas. J Pathol, eScholarID:239380 | PMID:25143307 | DOI:10.1002/path.4427
  • Smith, M., Wallace, A., Bowers, N., Eaton, H. & Evans, D (2014). SMARCB1 mutations in schwannomatosis and genotype correlations with rhabdoid tumors. Cancer Genet, eScholarID:239111 | PMID:24933152 | DOI:10.1016/j.cancergen.2014.04.001
  • Smith, M., Wallace, A., Bowers, N., Eaton, H. & Evans, D (2014). SMARCB1 mutations in schwannomatosis and genotype correlations with rhabdoid tumors. Cancer Genet, eScholarID:239145 | PMID:24933152 | DOI:10.1016/j.cancergen.2014.04.001
  • Smith, M., Wallace, A., Bowers, N., Eaton, H. & Evans, D (2014). SMARCB1 mutations in schwannomatosis and genotype correlations with rhabdoid tumors. Cancer Genet, eScholarID:239394 | PMID:24933152 | DOI:10.1016/j.cancergen.2014.04.001
  • Whitworth, J., Hoffman, J., Chapman, C., Ong, K., Lalloo, F., Evans, D. & Maher, E (2014). A clinical and genetic analysis of multiple primary cancer referrals to genetics services. Eur J Hum Genet, eScholarID:239087 | PMID:25248401 | DOI:10.1038/ejhg.2014.157
  • Whitworth, J., Hoffman, J., Chapman, C., Ong, K., Lalloo, F., Evans, D. & Maher, E (2014). A clinical and genetic analysis of multiple primary cancer referrals to genetics services. Eur J Hum Genet, eScholarID:239373 | PMID:25248401 | DOI:10.1038/ejhg.2014.157
  • Yasar, B., Byers, H., Smith, M., Lear, J., Oudit, D., Bholah, Z., Roberts, S., Newman, W. & Evans, D (2014). Common variants modify the age of onset for basal cell carcinomas in Gorlin syndrome. Eur J Hum Genet, eScholarID:239093 | PMID:25159867 | DOI:10.1038/ejhg.2014.167
  • Yasar, B., Byers, H., Smith, M., Lear, J., Oudit, D., Bholah, Z., Roberts, S., Newman, W. & Evans, D (2014). Common variants modify the age of onset for basal cell carcinomas in Gorlin syndrome. Eur J Hum Genet, eScholarID:239378 | PMID:25159867 | DOI:10.1038/ejhg.2014.167

2013

  • Barrow, E., Hill, J. & Evans, D (2013). Cancer risk in Lynch Syndrome. Fam Cancer, 12(2), 229-40. eScholarID:210715 | PMID:23604856 | DOI:10.1007/s10689-013-9615-1
  • Barrow, E., Newton, K., Rajashanker, B., Lee, S., Evans, D. & Hill, J (2013). Successful radiofrequency ablation of an anterior abdominal wall desmoid in familial adenomatous polyposis. Colorectal Dis, 15(3), e160-3. eScholarID:210739 | PMID:23067141 | DOI:10.1111/codi.12064
  • Barrow, P., Ingham, S., O'Hara, C., Green, K., McIntyre, I., Lalloo, F., Hill, J. & Evans, D (2013). The spectrum of urological malignancy in Lynch syndrome. Fam Cancer, 12(1), 57-63. eScholarID:210743 | PMID:23054215 | DOI:10.1007/s10689-012-9573-z
  • Barrow, P., Khan, M., Lalloo, F., Evans, D. & Hill, J (2013). Systematic review of the impact of registration and screening on colorectal cancer incidence and mortality in familial adenomatous polyposis and Lynch syndrome. Br J Surg, 100(13), 1719-31. eScholarID:239114 | PMID:24227356 | DOI:10.1002/bjs.9316
  • Barrow, P., Khan, M., Lalloo, F., Evans, D. & Hill, J (2013). Systematic review of the impact of registration and screening on colorectal cancer incidence and mortality in familial adenomatous polyposis and Lynch syndrome. Br J Surg, 100(13), 1719-31. eScholarID:239395 | PMID:24227356 | DOI:10.1002/bjs.9316
  • Basu, N., Littlechild, S., Evans, D., Ross, G. & Barr, L (2013). Mastectomies of healthy, contralateral breasts in patients with breast cancer. Br J Hosp Med (Lond), 74(9), 486-7. eScholarID:210744 | PMID:24022547
  • Ben-Shachar, S., Constantini, S., Hallevi, H., Sach, E., Upadhyaya, M., Evans, G. & Huson, S (2013). Increased rate of missense/in-frame mutations in individuals with NF1-related pulmonary stenosis: a novel genotype-phenotype correlation. Eur J Hum Genet, 21(5), 535-9. eScholarID:210788 | PMID:23047742 | DOI:10.1038/ejhg.2012.221
  • Ben-Shachar, S., Constantini, S., Hallevi, H., Sach, E., Upadhyaya, M., Evans, G. & Huson, S (2013). Increased rate of missense/in-frame mutations in individuals with NF1-related pulmonary stenosis: a novel genotype-phenotype correlation. Eur J Hum Genet, 21(5), 535-9. eScholarID:239121 | PMID:23047742 | DOI:10.1038/ejhg.2012.221
  • Ben-Shachar, S., Constantini, S., Hallevi, H., Sach, E., Upadhyaya, M., Evans, G. & Huson, S (2013). Increased rate of missense/in-frame mutations in individuals with NF1-related pulmonary stenosis: a novel genotype-phenotype correlation. Eur J Hum Genet, 21(5), 535-9. eScholarID:239136 | PMID:23047742 | DOI:10.1038/ejhg.2012.221
  • Bojesen, et al (2013). Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet, 45(4), 371-84, 384e1-2. eScholarID:210733 | PMID:23535731 | DOI:10.1038/ng.2566
  • Burkitt Wright, E., Sach, E., Sharif, S., Quarrell, O., Carroll, T., Whitehouse, R., Upadhyaya, M., Huson, S. & Evans, D (2013). Can the diagnosis of NF1 be excluded clinically? A lack of pigmentary findings in families with spinal neurofibromatosis demonstrates a limitation of clinical diagnosis. J Med Genet, 50(9), 606-13. eScholarID:210711 | PMID:23812910 | DOI:10.1136/jmedgenet-2013-101648
  • Castro, E., Goh, C., Olmos, D., Saunders, E., Leongamornlert, D., Tymrakiewicz, M., Mahmud, N., Dadaev, T., Govindasami, K., Guy, M., Sawyer, E., Wilkinson, R., Ardern-Jones, A., Ellis, S., Frost, D., Peock, S., Evans, D., Tischkowitz, M., Cole, T., Davidson, R., Eccles, D., Brewer, C., Douglas, F., Porteous, M., Donaldson, A., Dorkins, H., Izatt, L., Cook, J., Hodgson, S., Kennedy, M., Side, L., Eason, J., Murray, A., Antoniou, A., Easton, D., Kote-Jarai, Z. & Eeles, R (2013). Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer. J Clin Oncol, 31(14), 1748-57. eScholarID:210723 | PMID:23569316 | DOI:10.1200/JCO.2012.43.1882
  • Couch, et al. (2013). Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. PLoS Genet, 9(3), e1003212. eScholarID:210722 | PMID:23544013 | DOI:10.1371/journal.pgen.1003212
  • Den Heijer, M., van Asperen, C., Harris, H., Nippert, I., Schmidtke, J., Bouhnik, A., Julian-Reynier, C., Evans, D. & Tibben, A (2013). International variation in physicians' attitudes towards prophylactic mastectomy - comparison between France, Germany, the Netherlands and the United Kingdom. Eur J Cancer, 49(13), 2798-805. eScholarID:210724 | PMID:23692813 | DOI:10.1016/j.ejca.2013.04.025
  • Dombi, E., Ardern-Holmes, S., Babovic-Vuksanovic, D., Barker, F., Connor, S., Evans, D., Fisher, M., Goutagny, S., Harris, G., Jaramillo, D., Karajannis, M., Korf, B., Mautner, V., Plotkin, S., Poussaint, T., Robertson, K., Shih, C., Widemann, B. & . (2013). Recommendations for imaging tumor response in neurofibromatosis clinical trials. Neurology, 81(21 Suppl 1), S33-40. eScholarID:239106 | PMID:24249804 | DOI:10.1212/01.wnl.0000435744.57038.af
  • Dombi, E., Ardern-Holmes, S., Babovic-Vuksanovic, D., Barker, F., Connor, S., Evans, D., Fisher, M., Goutagny, S., Harris, G., Jaramillo, D., Karajannis, M., Korf, B., Mautner, V., Plotkin, S., Poussaint, T., Robertson, K., Shih, C., Widemann, B. & . (2013). Recommendations for imaging tumor response in neurofibromatosis clinical trials. Neurology, 81(21 Suppl 1), S33-40. eScholarID:239390 | PMID:24249804 | DOI:10.1212/01.wnl.0000435744.57038.af
  • Duffy, S., Mackay, J., Thomas, S., Anderson, E., Chen, T., Ellis, I., Evans, G., Fielder, H., Fox, R., Gui, G., Macmillan, D., Moss, S., Rogers, C., Sibbering, M., Wallis, M., Warren, R., Watson, E., Whynes, D., Allgood, P. & Caunt, J (2013). Evaluation of mammographic surveillance services in women aged 40-49 years with a moderate family history of breast cancer: a single-arm cohort study. Health Technol Assess, 17(11), vii-xiv, 1-95. eScholarID:210784 | PMID:23489892 | DOI:10.3310/hta17110
  • Duffy, S., Mackay, J., Thomas, S., Anderson, E., Chen, T., Ellis, I., Evans, G., Fielder, H., Fox, R., Gui, G., Macmillan, D., Moss, S., Rogers, C., Sibbering, M., Wallis, M., Warren, R., Watson, E., Whynes, D., Allgood, P. & Caunt, J (2013). Evaluation of mammographic surveillance services in women aged 40-49 years with a moderate family history of breast cancer: a single-arm cohort study. Health Technol Assess, 17(11), vii-xiv, 1-95. eScholarID:239131 | PMID:23489892 | DOI:10.3310/hta17110
  • Evans, D. & Ingham, S (2013). Reduced life expectancy seen in hereditary diseases which predispose to early-onset tumors. Appl Clin Genet, 6, 53-61. eScholarID:210737 | PMID:23935382 | DOI:10.2147/TACG.S35605
  • Evans, D. & Ingham, S (2013). Reduced life expectancy seen in hereditary diseases which predispose to early-onset tumors. Appl Clin Genet, 6, 53-61. eScholarID:239391 | PMID:23935382 | DOI:10.2147/TACG.S35605
  • Evans, D., Graham, J., O'Connell, S., Arnold, S. & Fitzsimmons, D (2013). Familial breast cancer: summary of updated NICE guidance. BMJ, 346, f3829. eScholarID:210721 | PMID:23801680
  • Evans, D., Howell, A., Ingham, S. & Buchan, I (2013). Contralateral breast cancer risk in BRCA1/2-positive families needs to be adjusted for phenocopy rates particularly in second-degree untested relatives. Breast Cancer Res, 15(1), 401. eScholarID:210717 | PMID:23448362 | DOI:10.1186/bcr3382
  • Evans, D., Ingham, S., Baildam, A., Ross, G., Lalloo, F., Buchan, I. & Howell, A (2013). Contralateral mastectomy improves survival in women with BRCA1/2-associated breast cancer. Breast Cancer Res Treat, 140(1), 135-42. eScholarID:210718 | PMID:23784379 | DOI:10.1007/s10549-013-2583-1
  • Evans, D., Ingham, S., Buchan, I., Woodward, E., Byers, H., Howell, A., Maher, E., Newman, W. & Lalloo, F (2013). Increased rate of phenocopies in all age groups in BRCA1/BRCA2 mutation kindred, but increased prospective breast cancer risk is confined to BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev, 22(12), 2269-76. eScholarID:239103 | PMID:24285840 | DOI:10.1158/1055-9965.EPI-13-0316-T
  • Evans, D., O'Hara, C., Wilding, A., Ingham, S., Howard, E., Dawson, J., Moran, A., Scott-Kitching, V., Holt, F. & Huson, S (2013). Mortality in neurofibromatosis 1: in North West England: an assessment of actuarial survival in a region of the UK since 1989. Eur J Hum Genet, 21(9), 1031. eScholarID:210745 | PMID:23949340 | DOI:10.1038/ejhg.2013.121
  • Evans, D., Thomas, S., Caunt, J., Roberts, L., Howell, A., Wilson, M., Fox, R., Sibbering, D., Moss, S., Wallis, M., Eccles, D., , & Duffy, S (2013). Mammographic surveillance in women aged 35-39 at enhanced familial risk of breast cancer (FH02). Fam Cancer, eScholarID:210728 | PMID:23733252 | DOI:10.1007/s10689-013-9661-8
  • Evans, D., Wallace, A. & Newman, W (2013). Can manipulation of splicing offer gene therapy possibilities to those with tumour-prone disorders? Eur J Hum Genet, 21(7), 701-2. eScholarID:210714 | PMID:23188050 | DOI:10.1038/ejhg.2012.264
  • Garg, S., Green, J., Leadbitter, K., Emsley, R., Lehtonen, A., Evans, D. & Huson, S (2013). Neurofibromatosis type 1 and autism spectrum disorder. Pediatrics, 132(6), e1642-8. eScholarID:239105 | PMID:24190681 | DOI:10.1542/peds.2013-1868
  • Garg, S., Green, J., Leadbitter, K., Emsley, R., Lehtonen, A., Evans, D. & Huson, S (2013). Neurofibromatosis type 1 and autism spectrum disorder. Pediatrics, 132(6), e1642-8. eScholarID:239388 | PMID:24190681 | DOI:10.1542/peds.2013-1868
  • Garg, S., Lehtonen, A., Huson, S., Emsley, R., Trump, D., Evans, D. & Green, J (2013). Autism and other psychiatric comorbidity in neurofibromatosis type 1: evidence from a population-based study. Dev Med Child Neurol, 55(2), 139-45. eScholarID:210709 | PMID:23163236 | DOI:10.1111/dmcn.12043
  • Gaudet, et al (2013). Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk. PLoS Genet, 9(3), e1003173. eScholarID:210741 | PMID:23544012 | DOI:10.1371/journal.pgen.1003173
  • Goorah, N., Singh, A., Stott, P., Levenson, R., Jordan, A., Joffe, J., Basu, N., Evans, D., Barr, L. & Sharma, N (2013). Correspondence - October 2013. Br J Hosp Med (Lond), 74(10), 594-595. eScholarID:210719 | PMID:24105318
  • Harvie, M., Wright, C., Pegington, M., McMullan, D., Mitchell, E., Martin, B., Cutler, R., Evans, G., Whiteside, S., Maudsley, S., Camandola, S., Wang, R., Carlson, O., Egan, J., Mattson, M. & Howell, A (2013). The effect of intermittent energy and carbohydrate restriction v. daily energy restriction on weight loss and metabolic disease risk markers in overweight women. Br J Nutr, 110(8), 1534-1547. eScholarID:210787 | PMID:23591120 | DOI:10.1017/S0007114513000792
  • Harvie, M., Wright, C., Pegington, M., McMullan, D., Mitchell, E., Martin, B., Cutler, R., Evans, G., Whiteside, S., Maudsley, S., Camandola, S., Wang, R., Carlson, O., Egan, J., Mattson, M. & Howell, A (2013). The effect of intermittent energy and carbohydrate restriction v. daily energy restriction on weight loss and metabolic disease risk markers in overweight women. Br J Nutr, 110(8), 1534-47. eScholarID:239142 | PMID:23591120 | DOI:10.1017/S0007114513000792
  • Howell, A. & Evans, D (2013). Breast cancer prevention: SERMs come of age. Lancet, 381(9880), 1795-7. eScholarID:210712 | PMID:23639489 | DOI:10.1016/S0140-6736(13)60443-2
  • Ingham, S., Sperrin, M., Baildam, A., Ross, G., Clayton, R., Lalloo, F., Buchan, I., Howell, A. & Evans, D (2013). Risk-reducing surgery increases survival in BRCA1/2 mutation carriers unaffected at time of family referral. Breast Cancer Res Treat, 142(3), 611-8. eScholarID:239110 | PMID:24249359 | DOI:10.1007/s10549-013-2765-x
  • Ingham, S., Sperrin, M., Baildam, A., Ross, G., Clayton, R., Lalloo, F., Buchan, I., Howell, A. & Evans, D (2013). Risk-reducing surgery increases survival in BRCA1/2 mutation carriers unaffected at time of family referral. Breast Cancer Res Treat, 142(3), 611-8. eScholarID:239393 | PMID:24249359 | DOI:10.1007/s10549-013-2765-x
  • Ingham, S., Warwick, J., Buchan, I., Sahin, S., O'Hara, C., Moran, A., Howell, A. & Evans, D (2013). Ovarian cancer among 8,005 women from a breast cancer family history clinic: no increased risk of invasive ovarian cancer in families testing negative for BRCA1 and BRCA2. J Med Genet, 50(6), 368-72. eScholarID:210735 | PMID:23539753 | DOI:10.1136/jmedgenet-2013-101607
  • Ingham, S., Warwick, J., Byers, H., Lalloo, F., Newman, W. & Evans, D (2013). Is multiple SNP testing in BRCA2 and BRCA1 female carriers ready for use in clinical practice? Results from a large Genetic Centre in the UK. Clin Genet, 84(1), 37-42. eScholarID:210725 | PMID:23050611 | DOI:10.1111/cge.12035
  • Jafri, M., Whitworth, J., Rattenberry, E., Vialard, L., Kilby, G., Kumar, A., Izatt, L., Lalloo, F., Brennan, P., Cook, J., Morrison, P., Canham, N., Armstrong, R., Brewer, C., Tomkins, S., Donaldson, A., Barwell, J., Cole, T., Atkinson, A., Aylwin, S., Ball, S., Srirangalingam, U., Chew, S., Evans, D., Hodgson, S., Irving, R., Woodward, E., Macdonald, F. & Maher, E (2013). Evaluation of SDHB, SDHD and VHL gene susceptibility testing in the assessment of individuals with non-syndromic phaeochromocytoma, paraganglioma and head and neck paraganglioma. Clin Endocrinol (Oxf), 78(6), 898-906. eScholarID:210747 | PMID:23072324 | DOI:10.1111/cen.12074
  • Killick, E., Morgan, R., Launchbury, F., Bancroft, E., Page, E., Castro, E., Kote-Jarai, Z., Aprikian, A., Blanco, I., Clowes, V., Domchek, S., Douglas, F., Eccles, D., Evans, D., Harris, M., Kirk, J., Lam, J., Lindeman, G., Mitchell, G., Pachter, N., Selkirk, C., Tucker, K., Zgajnar, J., Eeles, R. & Pandha, H (2013). Role of Engrailed-2 (EN2) as a prostate cancer detection biomarker in genetically high risk men. Sci Rep, 3, 2059. eScholarID:210736 | PMID:23792811 | DOI:10.1038/srep02059
  • Lloyd, S. & Evans, D (2013). Neurofibromatosis type 2 (NF2): diagnosis and management. Handb Clin Neurol, 115, 957-67. eScholarID:210731 | PMID:23931824 | DOI:10.1016/B978-0-444-52902-2.00054-0
  • Lucá, R., Averna, M., Zalfa, F., Vecchi, M., Bianchi, F., La Fata, G., Del Nonno, F., Nardacci, R., Bianchi, M., Nuciforo, P., Munck, S., Parrella, P., Moura, R., Signori, E., Alston, R., Kuchnio, A., Farace, M., Fazio, V., Piacentini, M., De Strooper, B., Achsel, T., Neri, G., Neven, P., Evans, D., Carmeliet, P., Mazzone, M. & Bagni, C (2013). The fragile X protein binds mRNAs involved in cancer progression and modulates metastasis formation. EMBO Mol Med, 5(10), 1523-36. eScholarID:239398 | PMID:24092663 | DOI:10.1002/emmm.201302847
  • Mavaddat, N., Peock, S., Frost, D., Ellis, S., Platte, R., Fineberg, E., Evans, D., Izatt, L., Eeles, R., Adlard, J., Davidson, R., Eccles, D., Cole, T., Cook, J., Brewer, C., Tischkowitz, M., Douglas, F., Hodgson, S., Walker, L., Porteous, M., Morrison, P., Side, L., Kennedy, M., Houghton, C., Donaldson, A., Rogers, M., Dorkins, H., Miedzybrodzka, Z., Gregory, H., Eason, J., Barwell, J., McCann, E., Murray, A., Antoniou, A., Easton, D. & . (2013). Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. J Natl Cancer Inst, 105(11), 812-22. eScholarID:210716 | PMID:23628597 | DOI:10.1093/jnci/djt095
  • Mesher, D., Dove-Edwin, I., Sasieni, P., Vasen, H., Bernstein, I., Royer-Pokora, B., Holinski-Feder, E., Lalloo, F., Evans, D., Forsberg, A., Lindblom, A. & Thomas, H (2013). A pooled analysis of the outcome of prospective colonoscopic surveillance for familial colorectal cancer. Int J Cancer, eScholarID:210713 | PMID:23901040 | DOI:10.1002/ijc.28397
  • Moffat, D., Lloyd, S., Macfarlane, R., Mannion, R., King, A., Rutherford, S., Axon, P., Donnelly, N., Freeman, S., Tysome, J., Evans, D. & Ramsden, R (2013). Outcome of translabyrinthine surgery for vestibular schwannoma in neurofibromatosis type 2. Br J Neurosurg, eScholarID:210732 | PMID:23472624 | DOI:10.3109/02688697.2013.771143
  • Newton, K., Green, K., Walsh, S., Lalloo, F., Hill, J. & Evans, D (2013). Metachronous colorectal cancer risk in patients with a moderate family history. Colorectal Dis, 15(3), 309-16. eScholarID:210746 | PMID:22943508 | DOI:10.1111/codi.12005
  • Nieuwenhuis, M., Kets, C., Murphy-Ryan, M., Yntema, H., Evans, D., Colas, C., Møller, P., Hes, F., Hodgson, S., Olderode-Berends, M., Aretz, S., Heinimann, K., Gómez García, E., Douglas, F., Spigelman, A., Timshel, S., Lindor, N. & Vasen, H (2013). Cancer risk and genotype-phenotype correlations in PTEN hamartoma tumor syndrome. Fam Cancer, eScholarID:210710 | PMID:23934601 | DOI:10.1007/s10689-013-9674-3
  • Palles, C., Cazier, J., Howarth, K., Domingo, E., Jones, A., Broderick, P., Kemp, Z., Spain, S., Guarino, E., Guarino Almeida, E., Salguero, I., Sherborne, A., Chubb, D., Carvajal-Carmona, L., Ma, Y., Kaur, K., Dobbins, S., Barclay, E., Gorman, M., Martin, L., Kovac, M., Humphray, S., , , , , Lucassen, A., Holmes, C., Bentley, D., Donnelly, P., Taylor, J., Petridis, C., Roylance, R., Sawyer, E., Kerr, D., Clark, S., Grimes, J., Kearsey, S., Thomas, H., McVean, G., Houlston, R. & Tomlinson, I (2013). Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas. Nat Genet, 45(2), 136-44. eScholarID:210785 | PMID:23263490 | DOI:10.1038/ng.2503
  • Palles, C., Cazier, J., Howarth, K., Domingo, E., Jones, A., Broderick, P., Kemp, Z., Spain, S., Guarino, E., Guarino Almeida, E., Salguero, I., Sherborne, A., Chubb, D., Carvajal-Carmona, L., Ma, Y., Kaur, K., Dobbins, S., Barclay, E., Gorman, M., Martin, L., Kovac, M., Humphray, S., , , , , Lucassen, A., Holmes, C., Bentley, D., Donnelly, P., Taylor, J., Petridis, C., Roylance, R., Sawyer, E., Kerr, D., Clark, S., Grimes, J., Kearsey, S., Thomas, H., McVean, G., Houlston, R. & Tomlinson, I (2013). Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas. Nat Genet, 45(2), 136-44. eScholarID:239137 | PMID:23263490 | DOI:10.1038/ng.2503
  • Pinheiro, M., Pinto, C., Peixoto, A., Veiga, I., Mesquita, B., Henrique, R., Lopes, P., Sousa, O., Fragoso, M., Dias, L., Baptista, M., Marinho, C., Mangold, E., Vaccaro, C., Evans, D., Farrington, S., Dunlop, M. & Teixeira, M (2013). The MSH2 c.388_389del mutation shows a founder effect in Portuguese Lynch syndrome families. Clin Genet, 84(3), 244-50. eScholarID:210740 | PMID:23170986 | DOI:10.1111/cge.12062
  • Plotkin, S., Ardern-Holmes, S., Barker, F., Blakeley, J., Evans, D., Ferner, R., Hadlock, T., Halpin, C. & . (2013). Hearing and facial function outcomes for neurofibromatosis 2 clinical trials. Neurology, 81(21 Suppl 1), S25-32. eScholarID:239098 | PMID:24249803 | DOI:10.1212/01.wnl.0000435746.02780.f6
  • Plotkin, S., Ardern-Holmes, S., Barker, F., Blakeley, J., Evans, D., Ferner, R., Hadlock, T., Halpin, C. & . (2013). Hearing and facial function outcomes for neurofibromatosis 2 clinical trials. Neurology, 81(21 Suppl 1), S25-32. eScholarID:239381 | PMID:24249803 | DOI:10.1212/01.wnl.0000435746.02780.f6
  • Rosenthal, A., Fraser, L., Manchanda, R., Badman, P., Philpott, S., Mozersky, J., Hadwin, R., Cafferty, F., Benjamin, E., Singh, N., Evans, D., Eccles, D., Skates, S., Mackay, J., Menon, U. & Jacobs, I (2013). Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening schedule. J Clin Oncol, 31(1), 49-57. eScholarID:210738 | PMID:23213100 | DOI:10.1200/JCO.2011.39.7638
  • Ruark, et al (2013). Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer. Nature, 493(7432), 406-10. eScholarID:210727 | PMID:23242139 | DOI:10.1038/nature11725
  • Ruark, et al (2013). Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer. Nature, 493(7432), 406-10. eScholarID:239141 | PMID:23242139 | DOI:10.1038/nature11725
  • Smith, M., O'Sullivan, J., Bhaskar, S., Hadfield, K., Poke, G., Caird, J., Sharif, S., Eccles, D., Fitzpatrick, D., Rawluk, D., du Plessis, D., Newman, W. & Evans, D (2013). Loss-of-function mutations in SMARCE1 cause an inherited disorder of multiple spinal meningiomas. Nat Genet, 45(3), 295-298. eScholarID:210730 | PMID:23377182 | DOI:10.1038/ng.2552
  • Tilanus-Linthorst, M., Lingsma, H., Evans, D., Thompson, D., Kaas, R., Manders, P., van Asperen, C., Adank, M., Hooning, M., Kwan Lim, G., Eeles, R., Oosterwijk, J., Leach, M. & Steyerberg, E (2013). Optimal age to start preventive measures in women with BRCA1/2 mutations or high familial breast cancer risk. Int J Cancer, 133(1), 156-63. eScholarID:210734 | PMID:23292943 | DOI:10.1002/ijc.28014
  • Tysome, J., Axon, P., Donnelly, N., Evans, D., Ferner, R., O'Connor, A., Freeman, S., Gleeson, M., Halliday, D., Harris, F., Jiang, D., Kerr, R., King, A., Knight, R., Lloyd, S., Macfarlane, R., Mannion, R., Mawman, D., O'Driscoll, M., Parry, A., Ramsden, J., Ramsden, R., Rutherford, S., Saeed, S., Thomas, N. & Vanat, Z (2013). English consensus protocol evaluating candidacy for auditory brainstem and cochlear implantation in neurofibromatosis type 2. Otol Neurotol, 34(9), 1743-7. eScholarID:239094 | PMID:24136318 | DOI:10.1097/MAO.0b013e3182a1a8b4
  • Tysome, J., Axon, P., Donnelly, N., Evans, D., Ferner, R., O'Connor, A., Freeman, S., Gleeson, M., Halliday, D., Harris, F., Jiang, D., Kerr, R., King, A., Knight, R., Lloyd, S., Macfarlane, R., Mannion, R., Mawman, D., O'Driscoll, M., Parry, A., Ramsden, J., Ramsden, R., Rutherford, S., Saeed, S., Thomas, N. & Vanat, Z (2013). English consensus protocol evaluating candidacy for auditory brainstem and cochlear implantation in neurofibromatosis type 2. Otol Neurotol, 34(9), 1743-7. eScholarID:239379 | PMID:24136318 | DOI:10.1097/MAO.0b013e3182a1a8b4
  • Valentini, A., Lubinski, J., Byrski, T., Ghadirian, P., Moller, P., Lynch, H., Ainsworth, P., Neuhausen, S., Weitzel, J., Singer, C., Olopade, O., Saal, H., Lyonnet, D., Foulkes, W., Kim-Sing, C., Manoukian, S., Zakalik, D., Armel, S., Senter, L., Eng, C., Grunfeld, E., Chiarelli, A., Poll, A., Sun, P., Narod, S. & . (2013). The impact of pregnancy on breast cancer survival in women who carry a BRCA1 or BRCA2 mutation. Breast Cancer Res Treat, 142(1), 177-85. eScholarID:239143 | PMID:24136669 | DOI:10.1007/s10549-013-2729-1
  • Valentini, A., Lubinski, J., Byrski, T., Ghadirian, P., Moller, P., Lynch, H., Ainsworth, P., Neuhausen, S., Weitzel, J., Singer, C., Olopade, O., Saal, H., Lyonnet, D., Foulkes, W., Kim-Sing, C., Manoukian, S., Zakalik, D., Armel, S., Senter, L., Eng, C., Grunfeld, E., Chiarelli, A., Poll, A., Sun, P., Narod, S. & . (2013). The impact of pregnancy on breast cancer survival in women who carry a BRCA1 or BRCA2 mutation. Breast Cancer Res Treat, 142(1), 177-85. eScholarID:239408 | PMID:24136669 | DOI:10.1007/s10549-013-2729-1
  • Wang, D., Chen, X., Evans, D. & Yang, W (2013). Well-dispersed Co3O4/Co2MnO4 nanocomposites as a synergistic bifunctional catalyst for oxygen reduction and oxygen evolution reactions. Nanoscale, 5(12), 5312-5. eScholarID:210742 | PMID:23681343 | DOI:10.1039/c3nr00444a

2012

  • Evans DG, Kwong A. (2012). Prevention of breast cancer: the genetics of breast cancer and risk reducing mastectomy. In Dixon MJ (Ed.), A companion to Specialist Surgical Practice in Breast Surgery. Philadelphia: Elsevier. eScholarID:155198
  • Sestak I, Cuzick J, Evans DG, Kwong A. (2012). Prevention of breast cancer. In Dixon MJ (Ed.), ABC of Breast Diseases. Chicago: Wiley-Blackwell. eScholarID:155199
  • Aavikko, M., Li, S., Saarinen, S., Alhopuro, P., Kaasinen, E., Morgunova, E., Li, Y., Vesanen, K., Smith, M., Evans, D., Pöyhönen, M., Kiuru, A., Auvinen, A., Aaltonen, L., Taipale, J. & Vahteristo, P (2012). Loss of SUFU function in familial multiple meningioma. Am J Hum Genet, 91(3), 520-6. eScholarID:210726 | PMID:22958902 | DOI:10.1016/j.ajhg.2012.07.015
  • Antoniou, et al. (2012). Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers. Breast Cancer Res, 14(1), R33. eScholarID:210757 | PMID:22348646 | DOI:10.1186/bcr3121
  • Barnes, D., Lee, A., , , , , Easton, D. & Antoniou, A (2012). Evaluation of association methods for analysing modifiers of disease risk in carriers of high-risk mutations. Genet Epidemiol, 36(3), 274-91. eScholarID:210763 | PMID:22714938 | DOI:10.1002/gepi.21620
  • Blakeley, J., Evans, D., Adler, J., Brackmann, D., Chen, R., Ferner, R., Hanemann, C., Harris, G., Huson, S., Jacob, A., Kalamarides, M., Karajannis, M., Korf, B., Mautner, V., McClatchey, A., Miao, H., Plotkin, S., Slattery, W., Stemmer-Rachamimov, A., Welling, D., Wen, P., Widemann, B., Hunter-Schaedle, K. & Giovannini, M (2012). Consensus recommendations for current treatments and accelerating clinical trials for patients with neurofibromatosis type 2. Am J Med Genet A, 158A(1), 24-41. eScholarID:210759 | PMID:22140088 | DOI:10.1002/ajmg.a.34359
  • Bolton et al. (2012). Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer. JAMA, 307(4), 382-390. eScholarID:154743 | DOI:10.1001/jama.2012.20
  • Bolton, et al. (2012). Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer. JAMA, 307(4), 382-90. eScholarID:210753 | PMID:22274685 | DOI:10.1001/jama.2012.20
  • Bolton, et al. (2012). Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer. JAMA, 307(4), 382-90. eScholarID:239127 | PMID:22274685 | DOI:10.1001/jama.2012.20
  • Camp, N., Parry, M., Knight, S., Abo, R., Elliott, G., Rigas, S., Balasubramanian, S., Reed, M., McBurney, H., Latif, A., Newman, W., Cannon-Albright, L., Evans, D. & Cox, A (2012). Fine-mapping CASP8 risk variants in breast cancer. Cancer Epidemiol Biomarkers Prev, 21(1), 176-81. eScholarID:210765 | PMID:22056502 | DOI:10.1158/1055-9965.EPI-11-0845
  • Couch, et al. (2012). Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev, 21(4), 645-57. eScholarID:210758 | PMID:22351618 | DOI:10.1158/1055-9965.EPI-11-0888
  • Ding, et al. (2012). A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev, 21(8), 1362-70. eScholarID:210751 | PMID:22729394 | DOI:10.1158/1055-9965.EPI-12-0229
  • Evans DG Lalloo F. (In-press). Familial Breast Cancer. Clin Genet, eScholarID:143970
  • Evans, D. & Howell, A (2012). Are we ready for online tools in decision making for BRCA1/2 mutation carriers? J Clin Oncol, 30(5), 471-3. eScholarID:210748 | PMID:22231044 | DOI:10.1200/JCO.2011.40.1562
  • Evans, D., Huson, S. & Birch, J (2012). Malignant peripheral nerve sheath tumours in inherited disease. Clin Sarcoma Res, 2(1), 17. eScholarID:210729 | PMID:23036231 | DOI:10.1186/2045-3329-2-17
  • Evans, D., Raymond, F., Barwell, J. & Halliday, D (2012). Genetic testing and screening of individuals at risk of NF2. Clin Genet, 82(5), 416-24. eScholarID:210769 | PMID:22098617 | DOI:10.1111/j.1399-0004.2011.01816.x
  • Evans, D., Warwick, J., Astley, S., Stavrinos, P., Sahin, S., Ingham, S., McBurney, H., Eckersley, B., Harvie, M., Wilson, M., Beetles, U., Warren, R., Hufton, A., Sergeant, J., Newman, W., Buchan, I., Cuzick, J. & Howell, A (2012). Assessing individual breast cancer risk within the U.K. National Health Service Breast Screening Program: a new paradigm for cancer prevention. Cancer Prev Res (Phila), 5(7), 943-51. eScholarID:210754 | PMID:22581816 | DOI:10.1158/1940-6207.CAPR-11-0458
  • Ferraldeschi, R., Arnedos, M., Hadfield, K., A'Hern, R., Drury, S., Wardley, A., Howell, A., Evans, D., Roberts, S., Smith, I., Newman, W. & Dowsett, M (2012). Polymorphisms of CYP19A1 and response to aromatase inhibitors in metastatic breast cancer patients. Breast Cancer Res Treat, 133(3), 1191-8. eScholarID:210777 | PMID:22418701 | DOI:10.1007/s10549-012-2010-z
  • Finch, A., Evans, G. & Narod, S (2012). BRCA carriers, prophylactic salpingo-oophorectomy and menopause: clinical management considerations and recommendations. Womens Health (Lond Engl), 8(5), 543-55. eScholarID:210782 | PMID:22934728 | DOI:10.2217/whe.12.41
  • Finch, A., Evans, G. & Narod, S (2012). BRCA carriers, prophylactic salpingo-oophorectomy and menopause: clinical management considerations and recommendations. Womens Health (Lond Engl), 8(5), 543-55. eScholarID:239125 | PMID:22934728 | DOI:10.2217/whe.12.41
  • Finkelman, B., Rubinstein, W., Friedman, S., Friebel, T., Dubitsky, S., Schonberger, N., Shoretz, R., Singer, C., Blum, J., Tung, N., Olopade, O., Weitzel, J., Lynch, H., Snyder, C., Garber, J., Schildkraut, J., Daly, M., Isaacs, C., Pichert, G., Neuhausen, S., Couch, F., van't Veer, L., Eeles, R., Bancroft, E., Evans, D., Ganz, P., Tomlinson, G., Narod, S., Matloff, E., Domchek, S. & Rebbeck, T (2012). Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriers. J Clin Oncol, 30(12), 1321-8. eScholarID:210749 | PMID:22430266 | DOI:10.1200/JCO.2011.37.8133
  • Hagel, C., Stemmer-Rachamimov, A., Bornemann, A., Schuhmann, M., Nagel, C., Huson, S., Evans, D., Plotkin, S., Matthies, C., Kluwe, L. & Mautner, V (2012). Clinical presentation, immunohistochemistry and electron microscopy indicate neurofibromatosis type 2-associated gliomas to be spinal ependymomas. Neuropathology, 32(6), 611-6. eScholarID:210756 | PMID:22394059 | DOI:10.1111/j.1440-1789.2012.01306.x
  • Heijnsdijk, E., Warner, E., Gilbert, F., Tilanus-Linthorst, M., Evans, G., Causer, P., Eeles, R., Kaas, R., Draisma, G., Ramsay, E., Warren, R., Hill, K., Hoogerbrugge, N., Wasser, M., Bergers, E., Oosterwijk, J., Hooning, M., Rutgers, E., Klijn, J., Plewes, D., Leach, M. & de Koning, H (2012). Differences in natural history between breast cancers in BRCA1 and BRCA2 mutation carriers and effects of MRI screening-MRISC, MARIBS, and Canadian studies combined. Cancer Epidemiol Biomarkers Prev, 21(9), 1458-68. eScholarID:210781 | PMID:22744338 | DOI:10.1158/1055-9965.EPI-11-1196
  • Heijnsdijk, E., Warner, E., Gilbert, F., Tilanus-Linthorst, M., Evans, G., Causer, P., Eeles, R., Kaas, R., Draisma, G., Ramsay, E., Warren, R., Hill, K., Hoogerbrugge, N., Wasser, M., Bergers, E., Oosterwijk, J., Hooning, M., Rutgers, E., Klijn, J., Plewes, D., Leach, M. & de Koning, H (2012). Differences in natural history between breast cancers in BRCA1 and BRCA2 mutation carriers and effects of MRI screening-MRISC, MARIBS, and Canadian studies combined. Cancer Epidemiol Biomarkers Prev, 21(9), 1458-68. eScholarID:239126 | PMID:22744338 | DOI:10.1158/1055-9965.EPI-11-1196
  • Howell A, Astley S, Warwick J, Stavrinos P, Sahin S, Ingham S, McBurney H, Eckersley B, Harvie M, Wilson M, Beetles U, Warren R, Hufton A, Sergeant J, Newman W, Buchan I, Cuzick J, Evans D. (2012). Prevention of Breast Cancer in the Context of a National Breast Screening Programme. eScholarID:155196
  • Howell, A., Astley, S., Warwick, J., Stavrinos, P., Sahin, S., Ingham, S., McBurney, H., Eckersley, B., Harvie, M., Wilson, M., Beetles, U., Warren, R., Hufton, A., Sergeant, J., Newman, W., Buchan, I., Cuzick, J. & Evans, D (2012). Prevention of breast cancer in the context of a national breast screening programme. J Intern Med, 271(4), 321-30. eScholarID:210776 | PMID:22292490 | DOI:10.1111/j.1365-2796.2012.02525.x
  • Iqbal, J., Ginsburg, O., Wijeratne, T., Howell, A., Evans, G., Sestak, I. & Narod, S (2012). Endometrial cancer and venous thromboembolism in women under age 50 who take tamoxifen for prevention of breast cancer: a systematic review. Cancer Treat Rev, 38(4), 318-28. eScholarID:210783 | PMID:21775065 | DOI:10.1016/j.ctrv.2011.06.009
  • Iqbal, J., Ginsburg, O., Wijeratne, T., Howell, A., Evans, G., Sestak, I. & Narod, S (2012). Endometrial cancer and venous thromboembolism in women under age 50 who take tamoxifen for prevention of breast cancer: a systematic review. Cancer Treat Rev, 38(4), 318-28. eScholarID:239128 | PMID:21775065 | DOI:10.1016/j.ctrv.2011.06.009
  • Jakubowska, et al. (2012). Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study. Br J Cancer, 106(12), 2016-24. eScholarID:210752 | PMID:22669161 | DOI:10.1038/bjc.2012.160
  • Kirchhoff, et al. (2012). Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2. PLoS One, 7(6), e35706. eScholarID:210755 | PMID:22768030 | DOI:10.1371/journal.pone.0035706
  • Lalloo, F. & Evans, D (2012). Familial breast cancer. Clin Genet, 82(2), 105-14. eScholarID:210764 | PMID:22356477 | DOI:10.1111/j.1399-0004.2012.01859.x
  • Maia, et al (2012). Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers. Breast Cancer Res, 14(2), R63. eScholarID:210761 | PMID:22513257 | DOI:10.1186/bcr3169
  • Mathers, J., Movahedi, M., Macrae, F., Mecklin, J., Moeslein, G., Olschwang, S., Eccles, D., Evans, G., Maher, E., Bertario, L., Bisgaard, M., Dunlop, M., Ho, J., Hodgson, S., Lindblom, A., Lubinski, J., Morrison, P., Murday, V., Ramesar, R., Side, L., Scott, R., Thomas, H., Vasen, H., Gerdes, A., Barker, G., Crawford, G., Elliott, F., Pylvanainen, K., Wijnen, J., Fodde, R., Lynch, H., Bishop, D., Burn, J. & . (2012). Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet Oncol, 13(12), 1242-9. eScholarID:210786 | PMID:23140761 | DOI:10.1016/S1470-2045(12)70475-8
  • Mathers, J., Movahedi, M., Macrae, F., Mecklin, J., Moeslein, G., Olschwang, S., Eccles, D., Evans, G., Maher, E., Bertario, L., Bisgaard, M., Dunlop, M., Ho, J., Hodgson, S., Lindblom, A., Lubinski, J., Morrison, P., Murday, V., Ramesar, R., Side, L., Scott, R., Thomas, H., Vasen, H., Gerdes, A., Barker, G., Crawford, G., Elliott, F., Pylvanainen, K., Wijnen, J., Fodde, R., Lynch, H., Bishop, D., Burn, J. & . (2012). Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet Oncol, 13(12), 1242-9. eScholarID:239139 | PMID:23140761 | DOI:10.1016/S1470-2045(12)70475-8
  • Mavaddat, et al. (2012). Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Cancer Epidemiol Biomarkers Prev, 21(1), 134-47. eScholarID:210775 | PMID:22144499 | DOI:10.1158/1055-9965.EPI-11-0775
  • Moran, A., O'Hara, C., Khan, S., Shack, L., Woodward, E., Maher, E., Lalloo, F. & Evans, D (2012). Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations. Fam Cancer, 11(2), 235-42. eScholarID:210778 | PMID:22187320 | DOI:10.1007/s10689-011-9506-2
  • Ormondroyd E, Donnelly L, Moynihan C, Savona C, Bancroft E, Evans DG, Eeles R, Lavery S, Watson M. (2012). Attitudes to reproductive genetic testing in women who had a positive BRCA test before having children: a qualitative analysis. Eur J Hum Genet, 20(1), 4-10. eScholarID:143912 | DOI:10.1038/ejhg.2011.146
  • Pijpe, A., Andrieu, N., Easton, D., Kesminiene, A., Cardis, E., Noguès, C., Gauthier-Villars, M., Lasset, C., Fricker, J., Peock, S., Frost, D., Evans, D., Eeles, R., Paterson, J., Manders, P., van Asperen, C., Ausems, M., Meijers-Heijboer, H., Thierry-Chef, I., Hauptmann, M., Goldgar, D., Rookus, M., van Leeuwen, F., , , , & . (2012). Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK). BMJ, 345, e5660. eScholarID:210720 | PMID:22956590
  • Pijpe, A., Andrieu, N., Easton, D., Kesminiene, A., Cardis, E., Noguès, C., Gauthier-Villars, M., Lasset, C., Fricker, J., Peock, S., Frost, D., Evans, D., Eeles, R., Paterson, J., Manders, P., van Asperen, C., Ausems, M., Meijers-Heijboer, H., Thierry-Chef, I., Hauptmann, M., Goldgar, D., Rookus, M., van Leeuwen, F., , , , & . (2012). Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK). BMJ, 345, e5660. eScholarID:239132 | PMID:22956590
  • Ramus et al. (2012). Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers. 22025.. eScholarID:154742
  • Ramus, et al. (2012). Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers. Hum Mutat, 33(4), 690-702. eScholarID:210774 | PMID:22253144 | DOI:10.1002/humu.22025
  • Robertson, L., Hanson, H., Seal, S., Warren-Perry, M., Hughes, D., Howell, I., Turnbull, C., Houlston, R., Shanley, S., Butler, S., Evans, D., Ross, G., Eccles, D., Tutt, A., Rahman, N., , & . (2012). BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 years. Br J Cancer, 106(6), 1234-8. eScholarID:210750 | PMID:22333603 | DOI:10.1038/bjc.2012.31
  • Robertson, L., Hanson, H., Seal, S., Warren-Perry, M., Hughes, D., Howell, I., Turnbull, C., Houlston, R., Shanley, S., Butler, S., Evans, D., Ross, G., Eccles, D., Tutt, A., Rahman, N., , & . (2012). BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 years. Br J Cancer, 106(6), 1234-8. eScholarID:239124 | PMID:22333603 | DOI:10.1038/bjc.2012.31
  • Rodriguez, F., Stratakis, C. & Evans, D (2012). Genetic predisposition to peripheral nerve neoplasia: diagnostic criteria and pathogenesis of neurofibromatoses, Carney complex, and related syndromes. Acta Neuropathol, 123(3), 349-67. eScholarID:210767 | PMID:22210082 | DOI:10.1007/s00401-011-0935-7
  • Sidon, L., Ingham, S., Clancy, T., Clayton, R., Clarke, A., Jones, E., Lalloo, F. & Evans, D (2012). Uptake of risk-reducing salpingo-oophorectomy in women carrying a BRCA1 or BRCA2 mutation: evidence for lower uptake in women affected by breast cancer and older women. Br J Cancer, 106(4), 775-9. eScholarID:210779 | PMID:22187038 | DOI:10.1038/bjc.2011.573
  • Smith, M., Kulkarni, A., Rustad, C., Bowers, N., Wallace, A., Holder, S., Heiberg, A., Ramsden, R. & Evans, D (2012). Vestibular schwannomas occur in schwannomatosis and should not be considered an exclusion criterion for clinical diagnosis. Am J Med Genet A, 158A(1), 215-9. eScholarID:210780 | PMID:22105938 | DOI:10.1002/ajmg.a.34376
  • Smith, M., Wallace, A., Bowers, N., Rustad, C., Woods, C., Leschziner, G., Ferner, R. & Evans, D (2012). Frequency of SMARCB1 mutations in familial and sporadic schwannomatosis. Neurogenetics, 13(2), 141-5. eScholarID:210766 | PMID:22434358 | DOI:10.1007/s10048-012-0319-8
  • Spurdle, A., Healey, S., Devereau, A., Hogervorst, F., Monteiro, A., Nathanson, K., Radice, P., Stoppa-Lyonnet, D., Tavtigian, S., Wappenschmidt, B., Couch, F., Goldgar, D. & . (2012). ENIGMA--evidence-based network for the interpretation of germline mutant alleles: an international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genes. Hum Mutat, 33(1), 2-7. eScholarID:210762 | PMID:21990146 | DOI:10.1002/humu.21628
  • Sullivan, W., Evans, D., Newman, W., Ramsden, S., Scheffer, H. & Payne, K (2012). Developing national guidance on genetic testing for breast cancer predisposition: the role of economic evidence? Genet Test Mol Biomarkers, 16(6), 580-91. eScholarID:210760 | PMID:22313048 | DOI:10.1089/gtmb.2011.0236
  • Turnbull, C., Seal, S., Renwick, A., Warren-Perry, M., Hughes, D., Elliott, A., Pernet, D., Peock, S., Adlard, J., Barwell, J., Berg, J., Brady, A., Brewer, C., Brice, G., Chapman, C., Cook, J., Davidson, R., Donaldson, A., Douglas, F., Greenhalgh, L., Henderson, A., Izatt, L., Kumar, A., Lalloo, F., Miedzybrodzka, Z., Morrison, P., Paterson, J., Porteous, M., Rogers, M., Shanley, S., Walker, L., , , Ahmed, M., Eccles, D., Evans, D., Donnelly, P., Easton, D., Stratton, M. & Rahman, N (2012). Gene-gene interactions in breast cancer susceptibility. Hum Mol Genet, 21(4), 958-62. eScholarID:210768 | PMID:22072393 | DOI:10.1093/hmg/ddr525
  • Turnbull, C., Seal, S., Renwick, A., Warren-Perry, M., Hughes, D., Elliott, A., Pernet, D., Peock, S., Adlard, J., Barwell, J., Berg, J., Brady, A., Brewer, C., Brice, G., Chapman, C., Cook, J., Davidson, R., Donaldson, A., Douglas, F., Greenhalgh, L., Henderson, A., Izatt, L., Kumar, A., Lalloo, F., Miedzybrodzka, Z., Morrison, P., Paterson, J., Porteous, M., Rogers, M., Shanley, S., Walker, L., , , Ahmed, M., Eccles, D., Evans, D., Donnelly, P., Easton, D., Stratton, M. & Rahman, N (2012). Gene-gene interactions in breast cancer susceptibility. Hum Mol Genet, 21(4), 958-62. eScholarID:239133 | PMID:22072393 | DOI:10.1093/hmg/ddr525
  • Wilding, A., Ingham, S., Lalloo, F., Clancy, T., Huson, S., Moran, A. & Evans, D (2012). Life expectancy in hereditary cancer predisposing diseases: an observational study. J Med Genet, 49(4), 264-9. eScholarID:210771 | PMID:22362873 | DOI:10.1136/jmedgenet-2011-100562

2011

  • Evans DGR, Lloyd SKW, Ramsden RTR. (2011). Neurofibromatosis type 2. Medical Genetics in the Clinical Practice of ORL. (pp. ). Karger,. eScholarID:143960
  • Antoniou et al. (2011). Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers. Hum Genet, 20(16), 3304-3321.. eScholarID:143855
  • Baser ME, Friedman JM, Joe H, Shenton A, Wallace AJ, Ramsden RT, Evans DG. (2011). Empirical development of improved diagnostic criteria for neurofibromatosis 2. Genet Med, 13(6), 576-581.. eScholarID:143826 | DOI:10.1097/GIM.0b013e318211faa9
  • Blakeley JO, Evans DG, Adler J, Brackmann D, Chen R, Ferner RE, Hanemann CO, Harris G, Huson SM, Jacob A, Kalamarides M, Karajannis MA, Korf BR, Mautner VF, McClatchey AI, Miao H, Plotkin SR, Slattery W 3rd, Stemmer-Rachamimov AO, Welling DB, Wen PY, Widemann B, Hunter-Schaedle K, Giovannini M. (2011). Consensus recommendations for current treatments and accelerating clinical trials for patients with neurofibromatosis type 2. eScholarID:143892
  • Bourdeaut F, Lequin D, Brugières L, Reynaud S, Dufour C, Doz F, André N, Stephan JL, Pérel Y, Oberlin O, Orbach D, Bergeron C, Rialland X, Fréneaux P, Ranchere D, Figarella-Branger D, Audry G, Puget S, Evans DG, Pinas JC, Capra V, Mosseri V, Coupier I, Gauthier-Villars M, Pierron G, Delattre O. (2011). Frequent hSNF5/INI1 Germline Mutations in Patients with Rhabdoid Tumor. Clin Cancer Res, 17(1), 31-38. eScholarID:121703 | DOI:10.1158/1078-0432.CCR-10-1795
  • Burn J, Bishop DT, Chapman PD, Elliott F, Bertario L, Dunlop MG, Eccles D, Ellis A, Evans DG, Fodde R, Maher ER, Möslein G, Vasen HF, Coaker J, Phillips RK, Bülow S, Mathers JC; for the International CAPP consortium. (2011). A Randomized Placebo-Controlled Prevention Trial of Aspirin and/or Resistant Starch in Young People with Familial Adenomatous Polyposis. Cancer Prev Res, 4(5), 655-665. eScholarID:143843 | DOI:10.1158/1940-6207.CAPR-11-0106
  • Burn J, Gerdes AM, Macrae F, Mecklin JP, Moeslein G, Olschwang S, Eccles D, Evans DG, Maher ER, Bertario L, Bisgaard ML, Dunlop MG, Ho JW, Hodgson SV, Lindblom A, Lubinski J, Morrison PJ, Murday V, Ramesar R, Side L, Scott RJ, Thomas HJ, Vasen HF, Barker G, Crawford G, Elliott F, Movahedi M, Pylvanainen K, Wijnen JT, Fodde R, Lynch HT, Mathers JC, Bishop DT; on behalf of the CAPP2 Investigators. (2011). Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. lancet, 378, 2081-2087. eScholarID:143864 | DOI:10.1016/S0140-6736(11)61049-0
  • Burn, J., Gerdes, A., Macrae, F., Mecklin, J., Moeslein, G., Olschwang, S., Eccles, D., Evans, D., Maher, E., Bertario, L., Bisgaard, M., Dunlop, M., Ho, J., Hodgson, S., Lindblom, A., Lubinski, J., Morrison, P., Murday, V., Ramesar, R., Side, L., Scott, R., Thomas, H., Vasen, H., Barker, G., Crawford, G., Elliott, F., Movahedi, M., Pylvanainen, K., Wijnen, J., Fodde, R., Lynch, H., Mathers, J., Bishop, D. & . (2011). Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet, 378(9809), 2081-7. eScholarID:210773 | PMID:22036019 | DOI:10.1016/S0140-6736(11)61049-0
  • Camp NJ, Parry M, Knight S, Abo R, Elliott G, Rigas SH, Balasubramanian SP, Reed MW, McBurney H, Latif A, Newman WG, Cannon-Albright LA, Evans DG, Cox A. (2011). Fine-mapping CASP8 risk variants in breast cancer. Cancer Epidemiol Biomarkers Prev, eScholarID:143880
  • Challberg J, Ashcroft L, Lalloo F, Eckersley B, Clayton R, Hopwood P, Selby P, Howell A, Evans DG. (2011). Menopausal symptoms and bone health in women undertaking risk reducing bilateral salpingo-oophorectomy: significant bone health issues in those not taking HRT. Br J Cancer, 105(1), 22-27. eScholarID:143847 | DOI:10.1038/bjc.2011.202
  • Cox et al. (2011). Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers. Hum Molec Genet, 20(23), 4732.-4747.. eScholarID:143871 | DOI:10.1093/hmg/ddr388
  • Evans DG, Howard E,Wilding A, Ingham SL, Moran A, Scott-Kitching V, Holt F, Huson SM. (2011). Mortality in neurofibromatosis 1. Eur J Hum Genet, 19(11), 1187.-1191.. eScholarID:143856
  • Evans DG, Howell A, Ward D, Lalloo F, Jones JL, Eccles DM. (2011). Prevalence of BRCA1 and BRCA2 mutations in triple negative breast cancer. J Med Genet, 48(8), 520-522. eScholarID:143849 | DOI:10.1136/jmedgenet-2011-100006
  • Evans DG, Raymond F, Barwell J, Halliday D. (2011). Genetic testing and screening of individuals at risk of NF2. Clin Genet, eScholarID:143890
  • Evans DGR. (2011). Medical Management of neurofibromatosis. Paediatrics and Child Health, 21(10), 459-466. eScholarID:143967 | DOI:10.1016/j.paed.2011.02.003
  • Evans GR, Lloyd SK, Ramsden RT. (2011). Neurofibromatosis type 2. 70, 91-98. eScholarID:143969
  • Evans, G., Lloyd, S. & Ramsden, R (2011). Neurofibromatosis type 2. Adv Otorhinolaryngol, 70, 91-8. eScholarID:239140 | PMID:21358190 | DOI:10.1159/000322482
  • Gadzicki D, Evans DG, Harris H, Julian-Reynier C, Nippert I, Schmidtke J, Tibben A, van Asperen C, Schlegelberger B. (2011). Genetic Testing for Familial/Hereditary Breast Cancer - Comparison of Guidelines and Recommendations from the United Kingdom, France, the Netherlands and Germany. J Community Genet, 2(2), 53-69. eScholarID:143828 | DOI:10.1007/s12687-011-0042-4
  • Harvie MN, Pegington M, Mattson MP, Frystyk J, Dillon B, Evans G, Cuzick J, Jebb SA, Martin B, Cutler RG, Son TG, Maudsley S, Carlson OD, Egan JM, Flyvbjerg A, Howell A. (2011). The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women. In J Obes, 35(5), 714-727.. eScholarID:143908 | DOI:10.1038/ijo.2010.171
  • Howell A, Evans DG. (2011). Hormone replacement therapy and breast cancer. Recent Results in Cancer Research, 188, 115-122. eScholarID:121701
  • Howell, A. & Evans, G (2011). Hormone replacement therapy and breast cancer. Recent Results Cancer Res, 188, 115-24. eScholarID:239135 | PMID:21253794 | DOI:10.1007/978-3-642-10858-7_10
  • Huson SM, Acosta MT, Belzberg AJ, Bernards A, Chernoff J, Cichowski K, Gareth Evans D, Ferner RE, Giovannini M, Korf BR, Listernick R, North KN, Packer RJ, Parada LF, Peltonen J, Ramesh V, Reilly KM, Risner JW, Schorry EK, Upadhyaya M, Viskochil DH, Zhu Y, Hunter-Schaedle K, Giancotti FG. (2011). Back to the future: Proceedings from the 2010 NF Conference. Am J Med Genet A, 155(2), 307-321. eScholarID:121707 | DOI:10.1002/ajmg.a.33804
  • Hutton J, Walker LG, Gilbert FJ, Evans DG, Eeles R, Kwan-Lim GE, Thompson D, Pointon LJ, Sharp DM, Leach MO. (2011). Psychological impact and acceptability of magnetic resonance imaging and X-ray mammography: the MARIBS Study. Br J Cancer, 104(4), 578-586. eScholarID:121708 | DOI:10.1038/bjc.2011.1
  • Im et al. (2011). Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers. Hum Genet, 130(5), 685-699. eScholarID:143852 | DOI:10.1007/s00439-011-1003-z
  • Ingham S, Huson SM, Moran A, Wylie J, Leahy M, Evans DG. (2011). Malignant peripheral nerve sheath tumours in NF1: Improved survival in women and in recent years. Eur J Cancer, 47(18), 2723-2728. eScholarID:143858 | DOI:10.1016/j.ejca.2011.05.031
  • Iqbal J, Ginsburg OM, Wijeratne TD, Howell A, Evans G, Sestak I, Narod SA. (In-press). Endometrial cancer and venous thromboembolism in women under age 50 who take tamoxifen for prevention of breast cancer: A systematic review. Cancer Treat Rev, eScholarID:143861
  • Kalamarides M, Acosta MT, Babovic-Vuksanovic D, Carpen O, Cichowski K, Gareth Evans D, Giancotti F, Oliver Hanemann C, Ingram D, Lloyd AC, Mayes DA, Messiaen L, Morrison H, North K, Packer R, Pan D, Stemmer-Rachamimov A, Upadhyaya M, Viskochil D, Wallace MR, Hunter-Schaedle K, Ratner N. (2011). Neurofibromatosis 2011: a report of the Children's Tumor Foundation Annual Meeting. Acta Neuropathol, eScholarID:143900
  • Knappskog S, Bjørnslett M, Myklebust LM, Huijts PE, Vreeswijk MP, Edvardsen H, Guo Y, Zhang X, Yang M, Ylisaukko-Oja SK, Alhopuro P, Arola J, Tollenaar RA, van Asperen CJ, Seynaeve C, Staalesen V, Chrisanthar R, Løkkevik E, Salvesen HB, Evans DG, Newman WG, Lin D, Aaltonen LA, Børresen-Dale AL, Tell GS, Stoltenberg C, Romundstad P, Hveem K, Lillehaug JR, Vatten L, Devilee P, Dørum A, Lønning PE. (2011). The MDM2 Promoter SNP285C/309G Haplotype Diminishes Sp1 Transcription Factor Binding and Reduces Risk for Breast and Ovarian Cancer in Caucasians. Cancer Cell, 19(2), 273-282. eScholarID:121710 | DOI:10.1016/j.ccr.2010.12.019
  • Loveday et al. (2011). Germline mutations in RAD51D confer susceptibility to ovarian cancer. Nat Genet, 43(9), 879.-882. eScholarID:143862 | DOI:10.1038/ng.893
  • Loveday, et al (2011). Germline mutations in RAD51D confer susceptibility to ovarian cancer. Nat Genet, 43(9), 879-82. eScholarID:239134 | PMID:21822267 | DOI:10.1038/ng.893
  • Martrat et al. (2011). Exploring the link between MORF4L1 and risk of breast cancer. Breast Cancer Res, 13(2), R40. eScholarID:143829 | DOI:10.1186/bcr2862
  • Maurice A, Evans DG, Affen J, Greenhalgh R, Duffy SW, Howell A. (2011). Surveillance of women at increased risk of breast cancer using mammography and clinical breast examination: Further evidence of benefit. Int J Cancer, eScholarID:143870
  • Mavaddat et al. (2011). Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Cancer Epid Biomarkers Prev, eScholarID:143895
  • Maxwell et al. (2011). Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer. Plos Biol, 9(11), eScholarID:143885
  • Maxwell, et al (2011). Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer. PLoS Biol, 9(11), e1001199. eScholarID:210772 | PMID:22110403 | DOI:10.1371/journal.pbio.1001199
  • Maxwell, et al (2011). Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer. PLoS Biol, 9(11), e1001199. eScholarID:239138 | PMID:22110403 | DOI:10.1371/journal.pbio.1001199
  • Moran A, O'Hara C, Khan S, Shack L, Woodward E, Maher ER, Lalloo F, Evans DG. (2011). Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations. Fam Cancer, eScholarID:143904
  • Mulligan et al. (2011). Common breast cancer susceptibility alleles are associated with tumor subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2. Breast Cancer Res, 13(6), R110. eScholarID:143881 | DOI:10.1186/bcr3052
  • Osorio et al. (2011). Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2. Brit J Cancer, 104(8), 1356-1361. eScholarID:143822 | DOI:10.1038/bjc.2011.91
  • Rebbeck TR, Mitra N, Domchek SM, Wan F, Klingner T, Tran TV, Singer CF, Tea MK, Blum JL, Tung N, Olopade OI, Weitzel JN, Lynch HT, Snyder C, Garber JE, Antoniou AC, Peock S, Evans DG, Paterson J, Kennedy JM, Donaldson A, Dorkins H, Easton DF, Rubinstein WS, Daly MB, Isaacs C, Nevanlinna H, Couch FJ, Andrulis IL, Friedman E, Laitman Y, Ganz PA, Tomlinson GE, Neuhausen SL, Narod SA, Phelan CM, Greenberg R, Nathanson KL. (2011). Modification of BRCA1-Associated Breast and Ovarian Cancer Risk by BRCA1 Interacting Genes. Cancer Res, 71(17), 5792-5805.. eScholarID:143866 | DOI:10.1158/0008-5472.CAN-11-0773
  • Sharif S, Upadhyaya M, Ferner R, Majounie E, Shenton A, Baser M, Thakker N, Evans DG. (2011). A molecular analysis of individuals with neurofibromatosis type 1 (NF1) and optic pathway gliomas (OPGs), and an assessment of genotype-phenotype correlations. J Med Genet, eScholarID:121704
  • Sidon L, Ingham S, Clancy T, Clayton R, Clarke A, Jones EA, Lalloo F, Evans DG. (2011). Uptake of risk-reducing salpingo-oophorectomy in women carrying a BRCA1 or BRCA2 mutation: evidence for lower uptake in women affected by breast cancer and older women. Br J Cancer, eScholarID:143907
  • Smith MJ, Higgs JE, Bowers NL, Halliday D, Paterson J, Gillespie J, Huson SM, Freeman SR, Lloyd S, Rutherford SA, King AT, Wallace AJ, Ramsden RT, Evans DG. (2011). Cranial meningiomas in 411 neurofibromatosis type 2 (NF2) patients with proven gene mutations: clear positional effect of mutations, but absence of female severity effect on age at onset. J Med Genet. 2011, eScholarID:121705
  • Smith MJ, Kulkarni A, Rustad C, Bowers NL, Wallace AJ, Holder SE, Heiberg A, Ramsden RT, Evans DG. (2011). Vestibular schwannomas occur in schwannomatosis and should not be considered an exclusion criterion for clinical diagnosis. Am J Med Genet A, eScholarID:143889
  • Speake, D., O'Sullivan, J., Evans, D., Lalloo, F., Hill, J. & McMahon, R (2011). Hyperplastic polyps are innocuous lesions in hereditary nonpolyposis colorectal cancers. Int J Surg Oncol, 2011, 653163. eScholarID:210770 | PMID:22312515 | DOI:10.1155/2011/653163
  • Thompson AM, Johnson A, Quinlan P, Hillman G, Fontecha M, Bray SE, Purdie CA, Jordan LB, Ferraldeschi R, Latif A, Hadfield KD, Clarke RB, Ashcroft L, Evans DG, Howell A, Nikoloff M, Lawrence J, Newman WG. (2011). Comprehensive CYP2D6 genotype and adherence affect outcome in breast cancer patients treated with tamoxifen monotherapy. Breast Cancer Res Treat, 125(1), 279-287. eScholarID:121685 | DOI:10.1007/s10549-010-1139-x
  • Turnbull C, Seal S, Renwick A, Warren-Perry M, Hughes D, Elliott A, Pernet D, Peock S, Adlard JW, Barwell J, Berg J, Brady AF, Brewer C, Brice G, Chapman C, Cook J, Davidson R, Donaldson A, Douglas F, Greenhalgh L, Henderson A, Izatt L, Kumar A, Lalloo F, Miedzybrodzka Z, Morrison PJ, Paterson J, Porteous M, Rogers MT, Shanley S, Walker L; Breast Cancer Susceptibility Collaboration (UK), EMBRACE, Ahmed M, Eccles D, Evans DG, Donnelly P, Easton DF, Stratton MR, Rahman N. (2011). Gene-gene interactions in breast cancer susceptibility. Hum Molec Genet, eScholarID:143887

2010

  • 378 Amir E, Freedman OC, Seruga B, Evans DG. (2010). Assessing Women at High Risk of Breast Cancer: A Review of Risk Assessment Models. J Natl Cancer Inst, 102(10), 680-691. eScholarID:121665 | DOI:10.1093/jnci/djq088
  • Antoniou et al. (2010). A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nat Genet, eScholarID:121689
  • Antoniou et al. (2010). Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction. Cancer Res, 70(23), 9742-9754. eScholarID:121695 | DOI:10.1158/0008-5472.CAN-10-1907
  • Barrow E, Evans DG, McMahon R, Hill J, Byers R. (2010). A comparative study of quantitative immunohistochemistry and quantum dot immunohistochemistry for mutation carrier identification in Lynch syndrome. J Clin Pathol, eScholarID:121702
  • Barrow E, Jagger E, Brierley J, Wallace A, Evans G, Hill J, McMahon R. (2010). Semiquantitative assessment of immunohistochemistry for mismatch repair proteins in Lynch syndrome. Histopathology, 56(3), 331-344. eScholarID:121667 | DOI:10.1111/j.1365-2559.2010.03485.x
  • Bergqvist J, Latif A, Roberts SA, Hadfield KD, Lalloo F, Howell A, Evans DG, Newman WG. (2010). RASSF1A polymorphism in familial breast cancer. Fam Cancer, 9(3), 263-265. eScholarID:121661 | DOI:10.1007/s10689-010-9335-8
  • Cairns SR, Scholefield JH, Steele RJ, Dunlop MG, Thomas HJ, Evans GD, Eaden JA, Rutter MD, Atkin WP, Saunders BP, Lucassen A, Jenkins P, Fairclough PD, Woodhouse CR; British Society of Gastroenterology; Association of Coloproctology for Great Britain and Ireland. (2010). Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). GUT, 59(5), 666-689. eScholarID:121666 | DOI:10.1136/gut.2009.179804
  • Consensus Recommendations to Accelerate Clinical Trials for Neurofibromatosis Type 2. (2010). Evans DG, Kalamarides M, Hunter-Schaedle K, Blakeley J, Allen J, Babovic-Vuskanovic D et al. Clinical Cancer Research, 15(16), 5032-5039. eScholarID:121653
  • Domchek SM, Friebel TM, Garber JE, Isaacs C, Matloff E, Eeles R, Evans DG, Rubinstein W, Singer CF, Rubin S, Lynch HT, Daly MB, Weitzel J, Ganz PA, Pichert G, Olopade OI, Tomlinson G, Tung N, Blum JL, Couch F, Rebbeck TR. (2010). Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers. Breast Cancer Res Treat, 124(1), 195-203. eScholarID:121662 | DOI:10.1007/s10549-010-0799-x
  • Domchek SM, Friebel TM, Singer CF, Evans DG, Lynch HT, Isaacs C, Garber JE, Neuhausen SL, Matloff E, Eeles R, Pichert G, Van t'veer L, Tung N, Weitzel JN, Couch FJ, Rubinstein WS, Ganz PA, Daly MB, Olopade OI, Tomlinson G, Schildkraut J, Blum JL, Rebbeck TR. (2010). Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. Journal of the American Medical Association, 304(9), 967-975. eScholarID:121684 | DOI:10.1001/jama.2010.1237
  • Edwards SM, Evans DG, Hope Q, Norman AR, Barbachano Y, Bullock S, Kote-Jarai Z, Meitz J, Falconer A, Osin P, Fisher C, Guy M, Jhavar SG, Hall AL, O'Brien LT, Gehr-Swain BN, Wilkinson RA, Forrest MS, Dearnaley DP, Ardern-Jones AT, Page EC, Easton DF, Eeles RA. (2010). Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis. Br J Cancer, 103(6), 918-924. eScholarID:121688 | DOI:10.1038/sj.bjc.6605822
  • Engel et al. (2010). Association of the Variants CASP8 D302H and CASP10 V410I with Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers. Cancer Epidemiol Biomarkers, eScholarID:121690
  • Evans DDGR, Lunt P, Clancy T, Eeles R. (2010). Childhood predictive genetic testing for Li-Fraumeni syndrome. Familial Cancer, 9, 65-69. eScholarID:1d20671 | DOI:10.1007/s10689-009-9245-9
  • Evans DG, Ahmed M, Bayliss S, Howard E, Lalloo F, Wallace A. (2010). BRCA1, BRCA2 and CHEK2 c.1100 delC mutations in patients with double primaries of the breasts and/or ovaries. J Med Genet, 47, 56-566. eScholarID:121674
  • Evans DG, Harvie M, Bundred N, Howell. (2010). Uptake of breast cancer prevention and screening trials. J Med Genet, 47(12), 853-855. eScholarID:121692 | DOI:10.1136/jmg.2010.082768
  • Evans DG, Howard E, Giblin C, Clancy T, Spencer H, Huson SM, Lalloo F. (2010). Birth incidence and prevalence of tumour prone syndromes: estimates from a UK genetic family register service. Am J Med Genet, 152A(2), 327-332. eScholarID:121658 | DOI:10.1002/ajmg.a.33139
  • Evans DG, Moran A, Hartley R, Dawson J, Bulman B, Knox F, Howell A, Lalloo F. (2010). L long term outcomes of breast cancer in women aged 30 years or younger, based on family history, pathology and BRCA1/BRCA2/TP53 status. Brit J Cancer, 102(7), 1091-1098. eScholarID:121660 | DOI:10.1038/sj.bjc.6605606
  • Evans DG, Susnerwala I, Dawson J, Woodward E, Maher ER, Lalloo F. (2010). Risk of breast cancer in male BRCA2 carriers. J Med Genet, 47(10), 710-711. eScholarID:121675 | DOI:10.1136/jmg.2009.075176
  • Evans GR, Lalloo F. (2010). Development of a scoring system to screen for BRCA1/2 mutations. Methods Mol Biol, 653, 237-247. eScholarID:121681 | DOI:10.1007/978-1-60761-759-4_14
  • FH01 collaborative teams. (2010). Mammographic surveillance in women younger than 50 years who have a family history of breast cancer: tumour characteristics and projected effect on mortality in the prospective, single-arm, FH01 study. Lancet Oncol, 11, 1127-1134. eScholarID:121698 | DOI:10.1016/S1470-2045(10)70263-1
  • Gaudet et al. (2010). Common genetic variants and modification of penetrance of BRCA2-associated breast cancer. PLoS Genet, 6(10), e100113. eScholarID:121697
  • Grindedal EM, Renkonen-Sinisalo L, Vasen H, Evans G, Sala P, Blanco I, Gronwald J, Apold J, Eccles DM, Sánchez AA, Sampson J, Järvinen HJ, Bertario L, Crawford GC, Stormorken AT, Maehle L, Møller P. (2010). Survival in women with MMR mutations and ovarian cancer; A multicentre study in Lynch Syndrome kindreds. J. Med Genet, 47, 99-102. eScholarID:121652 | DOI:10.1136/jmg.2009.068130
  • Hadfield KD, Smith MJ, Trump D, Newman WG, Evans DG. (2010). SMARCB1 mutations are not a common cause of multiple meningiomas. J Med Genet, 47, 567-568. eScholarID:121671 | DOI:10.1136/jmg.2009.075721
  • Hadfield KD, Smith MJ, Urquhart, JE, Wallace A, Bowers NL, Trump D, Newman WG, Evans DG. (2010). Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas. Oncogene, 29(47), 6216-6221. eScholarID:121677 | DOI:10.1038/onc.2010.363
  • Houlston et al. (2010). . Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33. NAT GENET, 42(11), 973-977. eScholarID:121691 | DOI:10.1038/ng.670
  • Latif A, Hadfield KD, Roberts SA, Shenton A, Lalloo F, Black GC, Howell A, Evans DG, Newman WG. (2010). Breast cancer susceptibility variants alter risks in familial disease. J Med Genet, 47, 126-131. eScholarID:121651 | DOI:10.1136/jmg.2009.067256
  • Latif A, McBurney HJ, Roberts SA, Lalloo F, Howell A, Evans DG, Newman WG. (2010). Breast cancer susceptibility variants alter risk in familial ovarian cancer. Fam Cancer, 9(4), 503-506. eScholarID:121676 | DOI:10.1007/s10689-010-9349-2
  • Mallinson EK, Newton KF, Bowen J, Lalloo F, Clancy T, Hill J, Evans DG. (2010). The impact of screening and genetic registration on mortality and colorectal cancer incidence in familial adenomatous polyposis. GUT, 59(10), 1378-1382. eScholarID:121682 | DOI:10.1136/gut.2010.212449
  • Neary WJ, Hillier VF, Flute T, Stephens SD, Ramsden RT, Evans DG. (2010). The relationship between patients' perception of the effects of neurofibromatosis type 2 and the domains of the Short Form-36. Clin Otolaryngol, 35(4), 291-299. eScholarID:121678 | DOI:10.1111/j.1749-4486.2010.02176.x
  • Neary WJ, Hillier VF, Flute T, Stephens SD, Ramsden RT, Evans DG. (2010). Use of a closed set questionnaire to measure primary and secondary effects of neurofibromatosis type 2. Journal of Laryngology & Otology, 124, 720-728. eScholarID:121680 | DOI:10.1017/S0022215110000460
  • Ramus et al. (2010). Genetic Variation at 9p22.2 and Ovarian Cancer Risk for BRCA1 and BRCA2 Mutation Carriers. J Natl Cancer Inst, eScholarID:121700
  • Selvanathan SK, Shenton A, Ferner R, Wallace AJ, Huson SM, Ramsden RT, Evans DG. (2010). Further Genotype-phenotype Correlations in Neurofibromatosis type 2. Clin Genet, 77(2), 163-170. eScholarID:121657 | DOI:10.1111/j.1399-0004.2009.01315.x
  • Smith MJ, Hadfield KD, Ramsden RT, Rutherford S, King A, Newman WG, Evans DG. (2010). Isolated Unilateral Vestibular Schwannomas Do Not Harbor HRAS Mutations. Am J Med Genet, 152A(6), 1586-1587. eScholarID:121668
  • Suryanarayanan R, Ramsden RT, Saeed SR, Aggarwal R, King AT, Rutherford SA, Evans DG, Gillespie JE. (2010). Vestibular schwannoma: role of conservative management. J Laryngol Otol, 124(3), 251-257. eScholarID:121656 | DOI:10.1017/S0022215109992362
  • Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study. (2010). Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study. BJU INT, eScholarID:121683
  • Tumor risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD. (2010). Ricketts CJ, Forman JR, Rattenberry E, Bradshaw N, Lalloo F, Izatt L, Cole TR, Armstrong R, Kumar VK, Morrison PJ, Atkinson AB, Douglas F, Ball SG, Cook J, Srirangalingam U, Killick P, Kirby G, Aylwin S, Woodward ER, Evans DG, Hodgson SV, Murday V, Chew SL, Connell JM, Blundell TL, Macdonald F, Maher ER. Hum Mutat, 31(1), 41-51. eScholarID:121654
  • Turnbull C, Ahmed S, Morrison J, Pernet D, Renwick A, Maranian M, Seal S, Ghoussaini M, Hines S, Healey CS, Hughes D, Warren-Perry M, Tapper W, Eccles D, Evans DG; The Breast Cancer Susceptibility Collaboration (UK), Hooning M, Schutte M, van den Ouweland A, Houlston R, Ross G, Langford C, Pharoah PD, Stratton MR, Dunning AM, Rahman N, Easton DF. (2010). Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet, 42(6), 504-507. eScholarID:121664 | DOI:10.1038/ng.586
  • Turnbull C, Hines S, Renwick A, Hughes D, Pernet D, Elliott A, Seal S, Warren-Perry M, Gareth Evans D, Eccles D; Breast Cancer Susceptibility Collaboration (UK), Stratton MR, Rahman N. (2010). Mutation and association analysis of GEN1 in breast cancer susceptibility. Breast Cancer Res Treat, 124(1), 283-288. eScholarID:121687 | DOI:10.1007/s10549-010-0949-1
  • Walker et al. (2010). . Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers. Breast Cancer Res, 12(6), R102. eScholarID:121696 | DOI:10.1186/bcr2785
  • Wellcome Trust Case Control Consortium. (2010). Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature, 464(7289), 713-720. eScholarID:121663 | DOI:10.1038/nature08979
  • Whitaker HC, Kote-Jarai Z, Ross-Adams H, Warren AY, Burge J, George A, Bancroft E, Jhavar S, Leongamornlert D, Tymrakiewicz M, Saunders E, Page E, Mitra A, Mitchell G, Lindeman GJ, Evans DG, Blanco I, Mercer C, Rubinstein WS, Clowes V, Douglas F, Hodgson S, Walker L, Donaldson A, Izatt L, Dorkins H, Male A, Tucker K, Stapleton A, Lam J, Kirk J, Lilja H, Easton D; IMPACT Study Steering Committee; IMPACT Study Collaborators; UK GPCS Collaborators, Cooper C, Eeles R, Neal DE. (2010). The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine. PLoS One.13;5(10):e13363, eScholarID:121694
  • Wilson JR, Bateman AC, Hanson H, An Q, Evans G, Rahman N, Jones JL, Eccles DM. (2010). A novel HER2-positive breast cancer phenotype arising from germline TP53 mutations. J Med Genet, 47(11), 771-774. eScholarID:121686 | DOI:10.1136/jmg.2010.078113

2009

  • (2009). Prevention of breast cancer: the genetics of breast cancer and risk reducing mastectomy. Breast Surgery: A companion to Specialist Surgical Practice. Elsevier. (pp. ). eScholarID:143966
  • Evans DGR, Baildam AD. Risk assessment and Management (2009). Risk assessment and Management. eScholarID:143961
  • (2009). Ahmed M, Lalloo F, Evans DG. Update on genetic predisposition to breast cancer. Expert Rev Anticancer Ther, 9(8):(8), 1103-1113. eScholarID:143971
  • Barrow E, Robinson L, Alduaij W, Shenton A, Clancy T, Lalloo F, Hill J, Evans DDGR. (2009). Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations. Clin Genet, 75( 2), eScholarID:1d20672 | DOI:10.1111/j.1399-0004.2008.01125.x
  • Evans DG, Gaarenstroom KN, Stirling D, Shenton A, Maehle L, Dørum A, Steel M, Lalloo F, Apold J, Porteous ME, Vasen HFA, van Asperen C, Moller P. (2009). Screening for Familial Ovarian Cancer: Poor survival of BRCA1/2 related cancers. J Med Genet, 46(9), 593-597. eScholarID:143935 | DOI:10.1136/jmg.2008.058248
  • Evans DG. (2009). Neurofibromatosis type 2 (NF2): A clinical and molecular review. Orphanet J Rare Dis, 4(16), eScholarID:143974

2008

  • Barrow E, Alduaij W, Robinson L, Shenton A, Clancy T, Lalloo F, Hill J, Evans DDGR. (2008). Colorectal cancer in HNPCC: cumulative lifetime incidence, survival and tumour distribution. A report of 121 families with proven mutations. Clin Genet, 74( 3), eScholarID:1d20673 | DOI:10.1111/j.1399-0004.2008.01035.x
  • Evans DDGR, Birch JM, Narod S. (2008). Is CHEK2 a cause of the Li-Fraumeni syndrome? J Med Genet, 45( 1), 63-4. eScholarID:1d19973 | DOI:10.1136/jmg.2007.054700
  • Evans DDGR, Wu C, Birch JM. (2008). BRCA2: a cause of Li-Fraumeni-like syndrome. J Med Genet, 45( 1), 62-3. eScholarID:1d19974 | DOI:10.1136/jmg.2007.054494

2007

  • Ferner, R, Huson, S, Thomas, N, Moss, C, Willshaw, H, Evans, DDGR, Upadhyaya, M, Towers, R, Gleeson, M, Steiger, C, Kirby, A. (2007). Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet, 44( 2), 81-8. eScholarID:1d20747 | DOI:10.1136/jmg.2006.045906

2005

  • Evans, DDGR, Baser, M, O'Reilly, B, Rowe, J, Gleeson, M, Saeed, S, King, A, Huson, S, Kerr, R, Thomas, N, Irving, R, MacFarlane, R, Ferner, R, McLeod, R, Moffat, D, Ramsden, R. (2005). Management of the patient and family with neurofibromatosis 2: a consensus conference statement. Br J Neurosurg, 19( 1), 5-12. eScholarID:1d30440 | DOI:10.1080/02688690500081206

2002

  • Baser ME, Friedman JM, Aeschilman D, Joe H, Wallace A, Ramsden RT, Evans DDGR. (2002). Predictors of the risk of mortality in neurofibromatosis 2. American Journal of Human Genetics, 71, 715-723. eScholarID:1d3817 | DOI:10.1086/342716
  • Bennett KE, Howell A-, Evans DDGR, Birch JM. (2002). A follow-up study of breast and other cancers in families of an unselected series of breast cancer patients. British Journal of Cancer, 86, 718-722. eScholarID:1d5295 | DOI:10.1038/sj.bjc.6600106
  • Evans DDGR, Baser M, McGaughran J, Sharif S, Howard E, Moran A. (2002). Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet, 39( 5), 311-4. eScholarID:1d30651
  • Evans DDGR, Thorneycroft M, McGown G, Lalloo F, Birch JM, Varley JM. (2002). Low rate of TP53 germline mutations in breast/sarcoma families not fulfilling classical criteria for Li Fraumeni syndrome. Journal of Medical Genetics, 39, 941-944. eScholarID:1d5303 | DOI:10.1136/jmg.39.12.941
  • Singhal S, Kerr B, Birch JM, Lashford L, Evans DDGR. (2002). Clinical characteristics of symptomatic sporadic and NF1 related optic gliomata: implications for management. Archives of Diseases in Childhood, 87, 65-70. eScholarID:1d4604

2001

  • Birch JM, Alston RD, McNally RJQ, Evans DDGR, Kelsey A, Eden OB, Varley JM. (2001). Relative frequency and morphology of cancers in carriers of germline TP53 mutations. Oncogene, 20, 4621-4628. eScholarID:1d2032 | DOI:10.1038/sj.onc.1204621

2000

  • Varley JM, Boyle JM, James LA, G McGown, Thorncroft M, Greaves M, Kelsey A, Evans DDGR, Birch JM. (2000). Genetic and cytogenetic studies in inherited cancer: Li Fraumeni syndrome. Chromosomes Today, 13, 245-255. eScholarID:1d4535
  • Woodford-Richens, K., Bevan, S., Churchman, M., Dowling, B., Jones, D., Norbury, C., Hodgson, S., Desai, D., Neale, K., Phillips, R., Young, J., Leggett, B., Dunlop, M., Rozen, P., Eng, C., Markie, D., Rodriguez-Bigas, M., Sheridan, E., Iwama, T., Eccles, D., Smith, G., Kim, J., Kim, K., Sampson, J., Evans, G., Tejpar, S., Bodmer, W., Tomlinson, I. & Houlston, R (2000). Analysis of genetic and phenotypic heterogeneity in juvenile polyposis. Gut, 46(5), 656-60. eScholarID:210868 | PMID:10764709

1999

  • Chang-Claude, J., Becher, H., Caligo, M., Eccles, D., Evans, G., Haites, N., Hodgson, S., Møller, P., Weber, B. & Stoppa-Lyonnet, D (1999). Risk estimation as a decision-making tool for genetic analysis of the breast cancer susceptibility genes. EC Demonstration Project on Familial Breast Cancer. Dis Markers, 15(1-3), 53-65. eScholarID:210880 | PMID:10595253
  • Douglas, F., O'Dair, L., Robinson, M., Evans, D. & Lynch, S (1999). The accuracy of diagnoses as reported in families with cancer: a retrospective study. J Med Genet, 36(4), 309-12. eScholarID:210858 | PMID:10227399
  • Eccles, D., Simmonds, P., Goddard, J., Coultas, M., Lalloo, F., Evans, G. & Haites, N (1999). Management of hereditary breast cancer. European Familial Breast Cancer Collaborative Group. Dis Markers, 15(1-3), 187-9. eScholarID:210878 | PMID:10595276
  • Evans, D (1999). Neurofibromatosis type 2: genetic and clinical features. Ear Nose Throat J, 78(2), 97-100. eScholarID:210855 | PMID:10089694
  • Evans, D., Anderson, E., Lalloo, F., Vasen, H., Beckmann, M., Eccles, D., Hodgson, S., Møller, P., Chang-Claude, J., Morrison, P., Stoppa-Lyonnet, D., Steel, M. & Haites, N (1999). Utilisation of prophylactic mastectomy in 10 European centres. Dis Markers, 15(1-3), 148-51. eScholarID:210860 | PMID:10595270
  • Evans, D., Birch, J. & Ramsden, R (1999). Paediatric presentation of type 2 neurofibromatosis. Arch Dis Child, 81(6), 496-9. eScholarID:210857 | PMID:10569966
  • Froggatt, N., Green, J., Brassett, C., Evans, D., Bishop, D., Kolodner, R. & Maher, E (1999). A common MSH2 mutation in English and North American HNPCC families: origin, phenotypic expression, and sex specific differences in colorectal cancer. J Med Genet, 36(2), 97-102. eScholarID:210834 | PMID:10051005
  • Hodgson, S., Milner, B., Brown, I., Bevilacqua, G., Chang-Claude, J., Eccles, D., Evans, G., Gregory, H., Møller, P., Morrison, P., Steel, M., Stoppa-Lyonnet, D., Vasen, H. & Haites, N (1999). Cancer genetics services in Europe. Dis Markers, 15(1-3), 3-13. eScholarID:210862 | PMID:10595245
  • Møller, P., Evans, G., Haites, N., Vasen, H., Reis, M., Anderson, E., Apold, J., Hodgson, S., Eccles, D., Olsson, H., Stoppa-Lyonnet, D., Chang-Claude, J., Morrison, P., Bevilacqua, G., Heimdal, K., Maehle, L., Lalloo, F., Gregory, H., Preece, P., Borg, A., Nevin, N., Caligo, M. & Steel, C (1999). Guidelines for follow-up of women at high risk for inherited breast cancer: consensus statement from the Biomed 2 Demonstration Programme on Inherited Breast Cancer. Dis Markers, 15(1-3), 207-11. eScholarID:210877 | PMID:10595280
  • Møller, P., Reis, M., Evans, G., Vasen, H., Haites, N., Anderson, E., Steel, C., Apold, J., Lalloo, F., Maehle, L., Preece, P., Gregory, H. & Heimdal, K (1999). Efficacy of early diagnosis and treatment in women with a family history of breast cancer. European Familial Breast Cancer Collaborative Group. Dis Markers, 15(1-3), 179-86. eScholarID:210867 | PMID:10595275
  • Morrison, P., Steel, C., Vasen, H., Eccles, D., Evans, D., Møller, P., Hodgson, S., Stoppa-Lyonnet, D., Chang-Claude, J., Caligo, M., Olah, E., Haites, N. & Nevin, N (1999). Insurance implications for individuals with a high risk of breast and ovarian cancer in Europe. Dis Markers, 15(1-3), 159-65. eScholarID:210852 | PMID:10595272
  • Richards, F., McKee, S., Rajpar, M., Cole, T., Evans, D., Jankowski, J., McKeown, C., Sanders, D. & Maher, E (1999). Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer. Hum Mol Genet, 8(4), 607-10. eScholarID:210846 | PMID:10072428
  • Roberts, S., Spreadborough, A., Bulman, B., Barber, J., Evans, D. & Scott, D (1999). Heritability of cellular radiosensitivity: a marker of low-penetrance predisposition genes in breast cancer? Am J Hum Genet, 65(3), 784-94. eScholarID:210849 | PMID:10441587 | DOI:10.1086/302544
  • Steel, M., Smyth, E., Vasen, H., Eccles, D., Evans, G., Møller, P., Hodgson, S., Stoppa-Lyonnet, D., Chang-Claude, J., Caligo, M., Morrison, P. & Haites, N (1999). Ethical, social and economic issues in familial breast cancer: a compilation of views from the E.C. Biomed II Demonstration Project. Dis Markers, 15(1-3), 125-31. eScholarID:210872 | PMID:10595265
  • Stoppa-Lyonnet, D., Caligo, M., Eccles, D., Evans, D., Haites, N., Hodgson, N., Møller, P., Morrison, P., Steel, C., Vasen, H. & Chang-Claude, J (1999). Genetic testing for breast cancer predisposition in 1999: which molecular strategy and which family criteria? Dis Markers, 15(1-3), 67-8. eScholarID:210844 | PMID:10595254
  • Stratton, J., Thompson, D., Bobrow, L., Dalal, N., Gore, M., Bishop, D., Scott, I., Evans, G., Daly, P., Easton, D. & Ponder, B (1999). The genetic epidemiology of early-onset epithelial ovarian cancer: a population-based study. Am J Hum Genet, 65(6), 1725-32. eScholarID:210882 | PMID:10577927 | DOI:10.1086/302671
  • Varley, JM, McGown, G, Thorncroft, M, James, LA, Margison, GP, Forster, G, Evans, DDGR, Harris, M, Kelsey, A, Birch, JM. (1999). Are there low-penetrance TP53 alleles? Evidence from Childhood Adrenocortical Tumours. American Journal of Human Genetics, 65, 995-1006. eScholarID:1d2030
  • Wang, Z., Churchman, M., Avizienyte, E., McKeown, C., Davies, S., Evans, D., Ferguson, A., Ellis, I., Xu, W., Yan, Z., Aaltonen, L. & Tomlinson, I (1999). Germline mutations of the LKB1 (STK11) gene in Peutz-Jeghers patients. J Med Genet, 36(5), 365-8. eScholarID:210848 | PMID:10353780

1998

  • Birch, J., Blair, V., Kelsey, A., Evans, D., Harris, M., Tricker, K. & Varley, J (1998). Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome. Oncogene, 17(9), 1061-8. eScholarID:210843 | PMID:9764816 | DOI:10.1038/sj.onc.1202033
  • Cooper, R., Slevin, N., Johnson, R. & Evans, G (1998). An unusual case of carotid body tumour. Clin Oncol (R Coll Radiol), 10(1), 62-4. eScholarID:210864 | PMID:9543619
  • Evans, D., Trueman, L., Wallace, A., Collins, S. & Strachan, T (1998). Genotype/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations. J Med Genet, 35(6), 450-5. eScholarID:210847 | PMID:9643284 | DOI:10.1136/jmg.35.6.450
  • Evans, D., Wallace, A., Wu, C., Trueman, L., Ramsden, R. & Strachan, T (1998). Somatic mosaicism: a common cause of classic disease in tumor-prone syndromes? Lessons from type 2 neurofibromatosis. Am J Hum Genet, 63(3), 727-36. eScholarID:210859 | PMID:9718334 | DOI:10.1086/512074
  • Kerr, B., Foulkes, W., Cade, D., Hadfield, L., Hopwood, P., Serruya, C., Hoare, E., Narod, S. & Evans, D (1998). False family history of breast cancer in the family cancer clinic. Eur J Surg Oncol, 24(4), 275-9. eScholarID:210841 | PMID:9724992
  • Lalloo, F., Boggis, C., Evans, D., Shenton, A., Threlfall, A. & Howell, A (1998). Screening by mammography, women with a family history of breast cancer. Eur J Cancer, 34(6), 937-40. eScholarID:210856 | PMID:9797712
  • Lalloo, F., Cochrane, S., Bulman, B., Varley, J., Elles, R., Howell, A. & Evans, D (1998). An evaluation of common breast cancer gene mutations in a population of Ashkenazi Jews. J Med Genet, 35(1), 10-2. eScholarID:210839 | PMID:9475087
  • McAllister, M., Evans, D., Ormiston, W. & Daly, P (1998). Men in breast cancer families: a preliminary qualitative study of awareness and experience. J Med Genet, 35(9), 739-44. eScholarID:210850 | PMID:9733032
  • Narod, S., Risch, H., Moslehi, R., Dørum, A., Neuhausen, S., Olsson, H., Provencher, D., Radice, P., Evans, G., Bishop, S., Brunet, J. & Ponder, B (1998). Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group. N Engl J Med, 339(7), 424-8. eScholarID:210876 | PMID:9700175 | DOI:10.1056/NEJM199808133390702
  • Varley, J., Chapman, P., McGown, G., Thorncroft, M., White, G., Greaves, M., Scott, D., Spreadborough, A., Tricker, K., Birch, J., Evans, D., Reddel, R., Camplejohn, R., Burn, J. & Boyle, J (1998). Genetic and functional studies of a germline TP53 splicing mutation in a Li-Fraumeni-like family. Oncogene, 16(25), 3291-8. eScholarID:210861 | PMID:9681828 | DOI:10.1038/sj.onc.1201878
  • Varley, J., McGown, G., Thorncroft, M., White, G., Tricker, K., Kelsey, A., Birch, J. & Evans, D (1998). A novel TP53 splicing mutation in a Li-Fraumeni syndrome family: a patient with Wilms' tumour is not a mutation carrier. Br J Cancer, 78(8), 1081-3. eScholarID:210837 | PMID:9792154
  • Vasen, H., Haites, N., Evans, D., Steel, C., Møller, P., Hodgson, S., Eccles, D., Morrison, P., Stoppa Lyonet, D., Chang-Claude, J. & Caligo, M (1998). Current policies for surveillance and management in women at risk of breast and ovarian cancer: a survey among 16 European family cancer clinics. European Familial Breast Cancer Collaborative Group. Eur J Cancer, 34(12), 1922-6. eScholarID:210842 | PMID:10023316

1997

  • Armstrong, J., Davies, D., Guy, S., Frayling, I. & Evans, D (1997). APC mutations in familial adenomatous polyposis families in the Northwest of England. Hum Mutat, 10(5), 376-80. eScholarID:210797 | PMID:9375853 | DOI:10.1002/(SICI)1098-1004(1997)10:5<376::AID-HUMU7>3.0.CO;2-D
  • Bijlsma, E., Wallace, A. & Evans, D (1997). Misleading linkage results in an NF2 presymptomatic test owing to mosaicism. J Med Genet, 34(11), 934-6. eScholarID:210853 | PMID:9391890
  • Evans, D., Mason, S., Huson, S., Ponder, M., Harding, A. & Strachan, T (1997). Spinal and cutaneous schwannomatosis is a variant form of type 2 neurofibromatosis: a clinical and molecular study. J Neurol Neurosurg Psychiatry, 62(4), 361-6. eScholarID:210826 | PMID:9120449
  • Evans, D., Walsh, S., Jeacock, J., Robinson, C., Hadfield, L., Davies, D. & Kingston, R (1997). Incidence of hereditary non-polyposis colorectal cancer in a population-based study of 1137 consecutive cases of colorectal cancer. Br J Surg, 84(9), 1281-5. eScholarID:210851 | PMID:9313714
  • Hoban, P., Cowen, R., Mitchell, E., Evans, D., Kelly, M., Howard, P. & Heighway, J (1997). Physical localisation of the breakpoints of a constitutional translocation t(5;6)(q21;q21) in a child with bilateral Wilms' tumour. J Med Genet, 34(4), 343-5. eScholarID:210821 | PMID:9138163
  • Moran, A., Collins, S., Evans, D. & Davies, R (1997). Risk of subsequent primary cancers in patients with carcinoma of the Ampulla of Vater. Br J Cancer, 76(9), 1232-3. eScholarID:210823 | PMID:9365175
  • Varley, J., Evans, D. & Birch, J (1997). Li-Fraumeni syndrome--a molecular and clinical review. Br J Cancer, 76(1), 1-14. eScholarID:210814 | PMID:9218725
  • Varley, J., McGown, G., Thorncroft, M., Santibanez-Koref, M., Kelsey, A., Tricker, K., Evans, D. & Birch, J (1997). Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families. Cancer Res, 57(15), 3245-52. eScholarID:210845 | PMID:9242456
  • Varley, J., Thorncroft, M., McGown, G., Appleby, J., Kelsey, A., Tricker, K., Evans, D. & Birch, J (1997). A detailed study of loss of heterozygosity on chromosome 17 in tumours from Li-Fraumeni patients carrying a mutation to the TP53 gene. Oncogene, 14(7), 865-71. eScholarID:210799 | PMID:9047394 | DOI:10.1038/sj.onc.1201041

1996

  • Brassett, C., Joyce, J., Froggatt, N., Williams, G., Furniss, D., Walsh, S., Miller, R., Evans, D. & Maher, E (1996). Microsatellite instability in early onset and familial colorectal cancer. J Med Genet, 33(12), 981-5. eScholarID:210816 | PMID:9004127
  • Colley, A., Donnai, D. & Evans, D (1996). Neurofibromatosis/Noonan phenotype: a variable feature of type 1 neurofibromatosis. Clin Genet, 49(2), 59-64. eScholarID:210818 | PMID:8740913
  • Froggatt, N., Brassett, C., Koch, D., Evans, D., Hodgson, S., Ponder, B. & Maher, E (1996). Mutation screening of MSH2 and MLH1 mRNA in hereditary non-polyposis colon cancer syndrome. J Med Genet, 33(9), 726-30. eScholarID:210854 | PMID:8880570
  • Maddock, I., Moran, A., Maher, E., Teare, M., Norman, A., Payne, S., Whitehouse, R., Dodd, C., Lavin, M., Hartley, N., Super, M. & Evans, D (1996). A genetic register for von Hippel-Lindau disease. J Med Genet, 33(2), 120-7. eScholarID:210794 | PMID:8929948
  • Neary, W., Newton, V., Laoide-Kemp, S., Ramsden, R., Griffith, G., Evans, D., Harris, R. & Strachan, T (1996). A clinical, genetic and audiological study of patients and families with unilateral vestibular schwannomas. I. Clinical features of neurofibromatosis in patients with unilateral vestibular schwannomas. J Laryngol Otol, 110(7), 634-40. eScholarID:210836 | PMID:8759535
  • Scott, R., Froggatt, N., Trembath, R., Evans, D., Hodgson, S. & Maher, E (1996). Familial infiltrative fibromatosis (desmoid tumours) (MIM135290) caused by a recurrent 3' APC gene mutation. Hum Mol Genet, 5(12), 1921-4. eScholarID:210807 | PMID:8968744
  • Thakker, N., Evans, D., Horner, K., Davies, D., Armstrong, J., Guy, S., Harris, R. & Sloan, P (1996). Florid oral manifestations in an atypical familial adenomatous polyposis family with late presentation of colorectal polyps. J Oral Pathol Med, 25(8), 459-62. eScholarID:210840 | PMID:8930826
  • Varley, J., McGown, G., Thorncroft, M., Cochrane, S., Morrison, P., Woll, P., Kelsey, A., Mitchell, E., Boyle, J., Birch, J. & Evans, D (1996). A previously undescribed mutation within the tetramerisation domain of TP53 in a family with Li-Fraumeni syndrome. Oncogene, 12(11), 2437-42. eScholarID:210838 | PMID:8649785
  • Varley, J., Thorncroft, M., McGown, G., Tricker, K., Birch, J. & Evans, D (1996). A novel deletion within exon 6 of TP53 in a family with Li-Fraumeni-like syndrome, and LOH in a benign lesion from a mutation carrier. Cancer Genet Cytogenet, 90(1), 14-6. eScholarID:210835 | PMID:8780740

1995

  • Bourn, D., Evans, G., Mason, S., Tekes, S., Trueman, L. & Strachan, T (1995). Eleven novel mutations in the NF2 tumour suppressor gene. Hum Genet, 95(5), 572-4. eScholarID:210869 | PMID:7759081
  • Evans, D., Blair, V., Strachan, T., Lye, R. & Ramsden, R (1995). Variation of expression of the gene for type 2 neurofibromatosis: absence of a gender effect on vestibular schwannomas, but confirmation of a preponderance of meningiomas in females. J Laryngol Otol, 109(9), 830-5. eScholarID:210831 | PMID:7494114
  • Evans, D., Bourn, D., Wallace, A., Ramsden, R., Mitchell, J. & Strachan, T (1995). Diagnostic issues in a family with late onset type 2 neurofibromatosis. J Med Genet, 32(6), 470-4. eScholarID:210805 | PMID:7666400
  • Froggatt, N., Koch, J., Davies, R., Evans, D., Clamp, A., Quarrell, O., Weissenbach, J., Hodgson, S., Ponder, B. & Barton, D (1995). Genetic linkage analysis in hereditary non-polyposis colon cancer syndrome. J Med Genet, 32(5), 352-7. eScholarID:210808 | PMID:7616541
  • Gayther, S., Warren, W., Mazoyer, S., Russell, P., Harrington, P., Chiano, M., Seal, S., Hamoudi, R., van Rensburg, E., Dunning, A., Love, R., Evans, G., Easton, D., Clayton, D., Stratton, M. & Ponder, B (1995). Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation. Nat Genet, 11(4), 428-33. eScholarID:210873 | PMID:7493024 | DOI:10.1038/ng1295-428
  • Gokhale, D., Evans, D., Crowther, D., Woll, P., Watson, C., Dearden, S., Fergusson, W., Stevens, R. & Taylor, G (1995). Molecular genetic analysis of a family with a history of Hodgkin's disease and dyschondrosteosis. Leukemia, 9(5), 826-33. eScholarID:210815 | PMID:7769845
  • Hodgson, S., Bishop, D., Dunlop, M., Evans, D. & Northover, J (1995). Suggested screening guidelines for familial colorectal cancer. J Med Screen, 2(1), 45-51. eScholarID:210828 | PMID:7497146
  • Joyce, J., Froggatt, N., Davies, R., Evans, D., Trembath, R., Barton, D. & Maher, E (1995). Molecular genetic analysis of exons 1 to 6 of the APC gene in non-polyposis familial colorectal cancer. Clin Genet, 48(6), 299-303. eScholarID:210817 | PMID:8835324
  • McGaughran, J., Ward, H. & Evans, D (1995). WAGR syndrome and multiple exostoses in a patient with del(11)(p11.2p14.2). J Med Genet, 32(10), 823-4. eScholarID:210832 | PMID:8558565
  • Thakker, N., Davies, R., Horner, K., Armstrong, J., Clancy, T., Guy, S., Harris, R., Sloan, P. & Evans, G (1995). The dental phenotype in familial adenomatous polyposis: diagnostic application of a weighted scoring system for changes on dental panoramic radiographs. J Med Genet, 32(6), 458-64. eScholarID:210881 | PMID:7666398
  • Varley, J., McGown, G., Thorncroft, M., Tricker, K., Teare, M., Santibanez-Koref, M., Martin, J., Birch, J. & Evans, D (1995). An extended Li-Fraumeni kindred with gastric carcinoma and a codon 175 mutation in TP53. J Med Genet, 32(12), 942-5. eScholarID:210796 | PMID:8825920

1994

  • Bourn, D., Carter, S., Evans, D., Goodship, J., Coakham, H. & Strachan, T (1994). A mutation in the neurofibromatosis type 2 tumor-suppressor gene, giving rise to widely different clinical phenotypes in two unrelated individuals. Am J Hum Genet, 55(1), 69-73. eScholarID:210795 | PMID:8023853
  • Evans, D., Blair, V., Greenhalgh, R., Hopwood, P. & Howell, A (1994). The impact of genetic counselling on risk perception in women with a family history of breast cancer. Br J Cancer, 70(5), 934-8. eScholarID:210825 | PMID:7947100
  • Evans, D., Fentiman, I., McPherson, K., Asbury, D., Ponder, B. & Howell, A (1994). Familial breast cancer. BMJ, 308(6922), 183-7. eScholarID:210811 | PMID:8312772
  • Evans, D., Rees, H., Spreadborough, A., Campbell, D., Gau, G., Pickering, E., Hamilton, S. & Clayton-Smith, J (1994). Radial ray defects, renal ectopia, duodenal atresia and hydrocephalus: the extended spectrum for Fanconi anaemia. Clin Dysmorphol, 3(3), 200-6. eScholarID:210822 | PMID:7981854
  • Richards, F., Crossey, P., Phipps, M., Foster, K., Latif, F., Evans, G., Sampson, J., Lerman, M., Zbar, B. & Affara, N (1994). Detailed mapping of germline deletions of the von Hippel-Lindau disease tumour suppressor gene. Hum Mol Genet, 3(4), 595-8. eScholarID:210863 | PMID:8069305
  • Rubinsztein, D., Hanlon, C., Irving, R., Goodburn, S., Evans, D., Kellar-Wood, H., Xuereb, J., Bandmann, O. & Harding, A (1994). Apo E genotypes in multiple sclerosis, Parkinson's disease, schwannomas and late-onset Alzheimer's disease. Mol Cell Probes, 8(6), 519-25. eScholarID:210800 | PMID:7700274
  • Ruttledge, M., Xie, Y., Han, F., Giovannini, M., Janson, M., Fransson, I., Werelius, B., Delattre, O., Thomas, G. & Evans, G (1994). Physical mapping of the NF2/meningioma region on human chromosome 22q12. Genomics, 19(1), 52-9. eScholarID:210875 | PMID:8188242
  • Steichen-Gersdorf, E., Gallion, H., Ford, D., Girodet, C., Easton, D., DiCioccio, R., Evans, G., Ponder, M., Pye, C. & Mazoyer, S (1994). Familial site-specific ovarian cancer is linked to BRCA1 on 17q12-21. Am J Hum Genet, 55(5), 870-5. eScholarID:210871 | PMID:7977348

1993

  • Evans, D., Burnell, L., Hopwood, P. & Howell, A (1993). Perception of risk in women with a family history of breast cancer. Br J Cancer, 67(3), 612-4. eScholarID:210830 | PMID:8439512
  • Evans, D., Guy, S., Thakker, N., Armstrong, J., Dodd, C., Davies, D., Babbs, C., Clancy, T., Warnes, T. & Sloan, P (1993). Non-penetrance and late appearance of polyps in families with familial adenomatous polyposis. Gut, 34(10), 1389-93. eScholarID:210820 | PMID:8244107
  • Evans, D., Ladusans, E., Rimmer, S., Burnell, L., Thakker, N. & Farndon, P (1993). Complications of the naevoid basal cell carcinoma syndrome: results of a population based study. J Med Genet, 30(6), 460-4. eScholarID:210802 | PMID:8326488
  • Evans, D., Ramsden, R., Huson, S., Harris, R., Lye, R. & King, T (1993). Type 2 neurofibromatosis: the need for supraregional care? J Laryngol Otol, 107(5), 401-6. eScholarID:210829 | PMID:8326218
  • Evans, G., Burnell, L., Campbell, R., Gattamaneni, H. & Birch, J (1993). Congenital anomalies and genetic syndromes in 173 cases of medulloblastoma. Med Pediatr Oncol, 21(6), 433-4. eScholarID:210865 | PMID:8515724
  • Neary, W., Newton, V., Vidler, M., Ramsden, R., Lye, R., Dutton, J., Richardson, P., Harris, R., Evans, D. & Strachan, T (1993). A clinical, genetic and audiological study of patients and families with bilateral acoustic neurofibromatosis. J Laryngol Otol, 107(1), 6-11. eScholarID:210789 | PMID:8445320
  • Shah, S., Evans, D., Blair, V., Burnell, L. & Birch, J (1993). Assessment of relative risk of second primary tumors after ovarian cancer and of the usefulness of double primary cases as a source of material for genetic studies with a cancer registry. Cancer, 72(3), 819-27. eScholarID:210803 | PMID:8334636
  • Teare, M., Santibáñez-Koref, M., Wallace, S., White, G., Evans, D., Burnell, L., Harris, M., Howell, A. & Birch, J (1993). A linkage study in seven breast cancer families. Am J Hum Genet, 52(4), 786-8. eScholarID:210793 | PMID:8460644
  • Watson, C., Gaunt, L., Evans, G., Patel, K., Harris, R. & Strachan, T (1993). A disease-associated germline deletion maps the type 2 neurofibromatosis (NF2) gene between the Ewing sarcoma region and the leukaemia inhibitory factor locus. Hum Mol Genet, 2(6), 701-4. eScholarID:210866 | PMID:8102569

1992

  • Evans, D., Huson, S., Donnai, D., Neary, W., Blair, V., Newton, V. & Harris, R (1992). A clinical study of type 2 neurofibromatosis. Q J Med, 84(304), 603-18. eScholarID:210790 | PMID:1484939
  • Evans, D., Huson, S., Donnai, D., Neary, W., Blair, V., Newton, V., Strachan, T. & Harris, R (1992). A genetic study of type 2 neurofibromatosis in the United Kingdom. II. Guidelines for genetic counselling. J Med Genet, 29(12), 847-52. eScholarID:210791 | PMID:1479599
  • Evans, D., Huson, S., Donnai, D., Neary, W., Blair, V., Teare, D., Newton, V., Strachan, T., Ramsden, R. & Harris, R (1992). A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity. J Med Genet, 29(12), 841-6. eScholarID:210792 | PMID:1479598
  • Evans, D., Ribiero, G., Warrell, D. & Donnai, D (1992). Ovarian cancer family and prophylactic choices. J Med Genet, 29(6), 416-8. eScholarID:210819 | PMID:1320125
  • Farndon, P., Del Mastro, R., Evans, D. & Kilpatrick, M (1992). Location of gene for Gorlin syndrome. Lancet, 339(8793), 581-2. eScholarID:210813 | PMID:1347096
  • Smith, S., Easton, D., Evans, D. & Ponder, B (1992). Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome. Nat Genet, 2(2), 128-31. eScholarID:210798 | PMID:1303261 | DOI:10.1038/ng1092-128

1991

  • Evans, D (1991). Dominantly inherited microcephaly, hypotelorism and normal intelligence. Clin Genet, 39(3), 178-80. eScholarID:210806 | PMID:2036738
  • Evans, D. & Lyon, A (1991). Fatal congenital cytomegalovirus infection acquired by an intra-uterine transfusion. Eur J Pediatr, 150(11), 780-1. eScholarID:210809 | PMID:1659984
  • Evans, D., Birch, J. & Orton, C (1991). Brain tumours and the occurrence of severe invasive basal cell carcinoma in first degree relatives with Gorlin syndrome. Br J Neurosurg, 5(6), 643-6. eScholarID:210801 | PMID:1772613
  • Evans, D., Farndon, P., Burnell, L., Gattamaneni, H. & Birch, J (1991). The incidence of Gorlin syndrome in 173 consecutive cases of medulloblastoma. Br J Cancer, 64(5), 959-61. eScholarID:210827 | PMID:1931625
  • Evans, D., Lonsdale, R. & Patton, M (1991). Cutaneous lymphangioma and amegakaryocytic thrombocytopenia in Noonan syndrome. Clin Genet, 39(3), 228-32. eScholarID:210804 | PMID:2036745
  • Evans, D., Robertson, D. & Bennett, J (1991). Space infections of the head and neck--the "new" clinical picture. J R Army Med Corps, 137(1), 35-7. eScholarID:210824 | PMID:2023168
  • Evans, D., Sims, D. & Donnai, D (1991). Family implications of neonatal Gorlin's syndrome. Arch Dis Child, 66(10 Spec No), 1162-3. eScholarID:210810 | PMID:1750770
  • Evans, D., Thakker, Y. & Donnai, D (1991). Heredity and dysmorphic syndromes in congenital limb deficiencies. Prosthet Orthot Int, 15(2), 70-7. eScholarID:210812 | PMID:1923725

1990

  • Evans, D., Evans, I., Donnai, D. & Lindenbaum, R (1990). Ankyloblepharon filiforme adnatum in trisomy 18 Edwards syndrome. J Med Genet, 27(11), 720-1. eScholarID:210833 | PMID:2277391

  • Bobrow, M., Harper, P., Harris, J., Evans, G. & Hunt, A Seminar on ethical issues arising from molecular studies in human genetic disease: held under the auspices of the UK Cancer Family Study Group in Manchester--21st May 1992. Dis Markers, 10(4), 185-7; discussion 211-28. eScholarID:210879 | PMID:1304436
  • Evans, G Ethical issues: the geneticist's view point. Dis Markers, 10(4), 199-203; discussion 211-28. eScholarID:210870 | PMID:1338981
  • Hopwood, P., Keeling, F., Long, A., Pool, C., Evans, G. & Howell, A Psychological support needs for women at high genetic risk of breast cancer: some preliminary indicators. Psychooncology, 7(5), 402-12. eScholarID:210874 | PMID:9809331 | DOI:10.1002/(SICI)1099-1611(1998090)7:5<402::AID-PON317>3.0.CO;2-X